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JOINT MODELS FOR LONGITUDINAL AND SURVIVAL DATA
Epidemiologic and clinical studies routinely collect longitudinal measures of multiple out-
comes. These longitudinal outcomes can be used to establish the temporal order of relevant
biological processes and their association with the onset of clinical symptoms. In the first
part of this thesis, we proposed to use bivariate change point models for two longitudi-
nal outcomes with a focus on estimating the correlation between the two change points.
We adopted a Bayesian approach for parameter estimation and inference. In the second
part, we considered the situation when time-to-event outcome is also collected along with
multiple longitudinal biomarkers measured until the occurrence of the event or censoring.
Joint models for longitudinal and time-to-event data can be used to estimate the association
between the characteristics of the longitudinal measures over time and survival time. We
developed a maximum-likelihood method to joint model multiple longitudinal biomarkers
and a time-to-event outcome. In addition, we focused on predicting conditional survival
probabilities and evaluating the predictive accuracy of multiple longitudinal biomarkers in
the joint modeling framework. We assessed the performance of the proposed methods in
simulation studies and applied the new methods to data sets from two cohort studies.
Sujuan Gao, Ph.D., Chair
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Chapter 1
Introduction
In this thesis research, several topics related to joint models for longitudinal and survival
data analysis were investigated. Longitudinal data analysis has been widely applied to a
single longitudinal outcome in various medical research areas, including basic science re-
search, clinical trials and epidemiological studies. In practice, however, many studies often
collect multiple longitudinal outcomes and joint models can be used to address interesting
scientific questions regarding the relationships among these multiple processes. In addition,
often times, a time-to-event outcome is also collected along with multiple longitudinal out-
comes in medical research studies. Joint models for multiple longitudinal outcomes and
time-to-event data can be used to assess the association between the time-to-event outcome
and multiple longitudinal outcomes.
We developed several novel approaches for analyzing multiple longitudinal outcomes,
and multiple longitudinal outcomes with time-to-event data. First, we introduce bivariate
random change point models for joint modeling of bivariate longitudinal outcomes. Second,
we present joint models for multiple longitudinal outcomes and time-to-event data. Fi-
nally, we focus on predicting conditional survival probabilities and evaluating the improved
predictive ability by adding new longitudinal biomarkers in the joint models.
1.1 Bivariate Random Change Point Models for Longitudinal Outcomes
In most longitudinal analysis a single longitudinal outcome, measured repeatedly over time,
was the focus of investigation on identifying the longitudinal trend or factors associated
with longitudinal change. For example, in longitudinal cohort studies of dementia, cognitive
1
function, activities of daily living (ADL), and physiological measures such as blood pressure
(BP), height and weight are collected repeatedly from participants over a relatively long
follow-up period. Many of these functional measures are assumed to be relatively stable
across the life span and may start to decline or increase with the onset of underlying
diseases. The time point when an individual start the decline is called a change point.
It is therefore of interest to determine the change point when individual declines on a
specific outcome. Furthermore, it is perhaps more interesting to determine whether the
change point of one longitudinal measure is associated with the change point of another
longitudinal measure, thus offering potential evidence of a temporal association linking two
or more biological processes. Our motivating example data for joint modeling of bivariate
longitudinal data came from dementia studies. It is well known that subjects with dementia
or cognitive impairment suffer weight loss, which was often attributed to the fact that
these subjects often forget to eat resulting in nutritional deficit. However, Buchman et al.
(2005) also reported that weight loss precedes dementia diagnosis. Thus, it is of scientific
interest to examine the temporal relationship between these two outcomes to determine
whether cognitive decline leads to weight loss or whether weight change precedes cognitive
impairment. In this research, we developed several bivariate random change point models
for two longitudinal outcomes with a particular focus on the correlation between the change
points of the two trajectories.
1.2 Joint Models for Multiple Longitudinal Processes and Time-to-event Out-
come
In both epidemiological and clinical trial studies, the time-to-event outcome is often col-
lected along with multiple longitudinal biomarkers that are repeatedly measured until the
occurrence of the event or censoring. There are two general joint modeling strategies with
2
different model interpretations discussed (Little, 1993; Little and Rubin, 2001). The pattern-
mixture model is used when the primary interest is inference of the longitudinal process
with the time-to-event outcome considered a missing data phenomenon. On the other hand,
if the primary inference is the time-to-event outcome and to determine whether the longitu-
dinal outcome is associated with the event process, selection models are more appropriate.
Sousa (2011) gave a brief introduction to the two types of joint modeling frameworks. In
the second topic of this dissertation research, we focus on the latter type of joint model -
the random selection model, which could be formulated as [Y, F, U ] = [U ][Y |U ][F |Y ], where
Y is the longitudinal measures, F is the time-to-event outcome, and U presents the random
effects.
Traditional survival models have typically characterized exposures by a single measure
at study baseline or as an average over a relatively short period of time. Such exposure
characterization fails to capture any changes or variability over the potentially long latency
period prior to an event. An extension to this standard survival model is the Cox model
involving time-dependent covariates using counting process formulation and partial like-
lihood theory (Andersen et al., 1993; Andersen and Gill, 1982; Fleming and Harrington,
1991). However, this model has a strong assumption that the time-dependent covariates
are measured without error and precisely predictable. In practice, this is not realistic be-
cause often times the longitudinal biomarker measures are not observed at the event or
censoring time point. Therefore, an ideal model should not only allow the examination
on the contribution from various attributes of the longitudinal outcomes in order to es-
tablish the association between the longitudinal outcome and the time to event but also
takes the measurement errors of the longitudinal biomarkers into account. With this strong
motivation, a framework of joint models of longitudinal and survival data was proposed
(Faucett and Thomas, 1996; Wulfsohn and Tsiatis, 1997). We focused on this type of joint
3
models with multiple longitudinal processes and a time-to-event outcome, and developed a
maximum-likelihood method for the parameter estimation.
1.3 Dynamic Predictions in Joint Models for Multiple Longitudinal Processes
and Time-to-event Outcome
In the second topic, we proposed a maximum-likelihood method for parameter estimation
of joint models for multiple longitudinal biomarkers and a time-to-event outcome, where
the main interest is to assess the associations between the multiple longitudinal biomarkers
and the risk of an event. The estimated associations can help researchers better understand
the relationship between the time-to-event outcome and multiple longitudinal biomarkers.
However, in reality, it may be more clinically relevant to study how well the longitudinal
biomarkers predict the event risk. In this work, we concentrated on predicting conditional
survival probabilities and assessing the predictive accuracy of the joint models of multiple
longitudinal biomarkers and a time-to-event outcome. In particular, we used traditional
criterion, the area under the receiver operating characteristic (ROC) curve (AUC) (Hanley
and McNeil, 1982), to evaluate the predictive accuracy. However, several studies have
demonstrated that AUC is not sensitive and appropriate in evaluating the improvement
in predictive ability by adding new biomarkers in the model (Cook, 2007; Harrell, 2001;
Janes et al., 2008; Moons and Harrell, 2003). In the past few years novel predictive criteria
have been proposed for binary and time-to-event outcomes, including the above average risk
difference(AARD) and the mean risk difference(MRD) (Pepe et al., 2008; Pepe and Janes,
2012). We applied AARD and MRD to the joint modeling framework and evaluated their
ability in quantifying the improved prediction by adding new longitudinal biomarkers.
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Chapter 2
Bivariate Random Change Point Models for Longitudinal Outcomes
2.1 Abstract
Epidemiologic and clinical studies routinely collect longitudinal measures of multiple out-
comes, including biomarker measures, cognitive functions, and clinical symptoms. These
longitudinal outcomes can be used to establish the temporal order of relevant biological pro-
cesses and their association with the onset of clinical symptoms. Univariate change point
models have been used to model various clinical endpoints, such as CD4 count in studying
the progression of HIV infection and cognitive function in the elderly. We proposed to use
bivariate change point models for two longitudinal outcomes with a focus on the correlation
between the two change points. Three types of change point models are considered in the
bivariate model setting: the broken-stick model, the Bacon-Watts model and the smooth
polynomial model. We adopted a Bayesian approach using a Markov chain Monte Carlo
sampling method for parameter estimation and inference. We assessed the proposed meth-
ods in simulation studies and demonstrated the methodology using data from a longitudinal
study of dementia.
2.2 Introduction
Longitudinal epidemiologic and clinical studies routinely collect repeated measures of multi-
ple outcomes. For example, in longitudinal studies of dementia, cognitive function measures,
activities of daily living (ADL) measures, physical function measures such as height and
weight, neurological measures, and psychosocial measures are collected repeatedly from par-
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ticipants over a relatively long follow-up period. In recent years, research on Alzheimer’s
disease (AD) has come to the consensus that both AD pathological processes and the clin-
ical decline occur gradually, with dementia at the end stage of many years of accumulation
of these pathological changes (Jack et al., 2010). An additional feature of AD is that biolog-
ical changes begin to develop decades before the presentation of earliest clinical symptoms.
Longitudinal measures of biomarkers, cognitive functions, and clinical symptoms will en-
able researchers to establish the temporal order of relevant biological processes and their
association with the onset of clinical symptoms.
Change point models are useful as an alternative to linear models to determine when
changes have taken place in an event window. Change point models with one change point
and two linear phases are most commonly used, because many biological mechanisms can
be readily modeled. To account for individual variability, random change point models have
been further formulated by including flexible subject-specific random effects to capture both
population trends and individual-level variations. Univariate change point models have been
used to model various clinical endpoints such as CD4 count in studying the progression of
HIV infection and AIDS (Ghosh and Vaida, 2007; Kiuchi et al., 1995; Lange et al., 1992)
and cognitive function in studying dementia in the elderly (Dominicus et al., 2008; Hall
et al., 2003; Jacqmin-Gadda et al., 2006; van den Hout et al., 2010).
The simple change point model with an abrupt transition is referred to as the broken-
stick model (Dominicus et al., 2008; Ghosh and Vaida, 2007; Kiuchi et al., 1995), which
has the advantage of detecting a significant departure in direction and volatility from the
immediate past. However, the broken-stick model is not always appropriate in practice
because a sudden change in direction may not be realistic. The non-continuity at the change
point of the broken-stick model may also cause numerical issues in parameter estimation.
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Two types of smooth change point models were proposed by van den Hout et al. (2010):
the Bacon-Watts model (Bacon and Watts, 1971) and a smooth polynomial model.
There have been a few studies on the joint modeling of bivariate random change point
model for longitudinal outcomes. Hall et al. (2001) simultaneously estimated two different
change points of two longitudinal measures of cognitive function. Jacqmin-Gadda et al.
(2006) constructed joint models between a random change point model for a longitudinal
outcome and a lognormal model for time-to-event data. In this paper, we consider bivariate
change point models for two longitudinal outcomes with a focus on the correlations be-
tween the two change points. Motivated by data from a longitudinal study of dementia, we
developed joint models for bivariate longitudinal outcomes under the aforementioned mod-
eling frameworks: the random broken-stick model, the random Bacon-Watts model and the
random smooth polynomial model. The proposed bivariate change point models take the
correlation structure into account and provide a useful framework to assess the correlation
between the two change points and their temporal order. The proposed methodology is ap-
plicable to other studies in which determining the order of biomarker changes is needed. We
adopted a Bayesian estimation approach using Markov chain Monte Carlo (MCMC) for a
computational and inferential framework for the bivariate random change point models. We
assessed the performance of the proposed method in simulation studies and demonstrated
the methodology using data from a longitudinal study of dementia.
The remainder of this chapter is organized as follows. Section 2.3 describes a longitudi-
nal study of dementia as a motivating example. In Section 2.4, we present three bivariate
random change point models, the Bayesian methodology for parameter estimation, and
statistical inference. A series of simulation studies were carried out to compare the perfor-
mances of the three joint models and results are presented in Section 2.5. In Section 2.6
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we apply the proposed methods to the example data set. We conclude with a discussion in
Section 2.7.
2.3 The Indianapolis-Ibadan Dementia Study
The Indianapolis-Ibadan Dementia Study (IIDS) is a longitudinal comparative epidemiol-
ogy study designed to investigate risk factors associated with dementia and AD. The study
enrolled and maintained two cohorts of elderly participants, one consisting of African Amer-
icans living in Indianapolis, Indiana, and the other consisting of Nigerians living in Ibadan,
Nigeria. Details about the study have been published (Hendrie et al., 2001, 1995). The
data used for the current paper come from the Indianapolis cohort. Briefly, 2212 African-
American adults aged 65 and older living in Indianapolis were enrolled in the study in 1992.
The study participants were followed for up to 17 years and underwent regularly sched-
uled cognitive assessments and clinical evaluations approximately every2 or 3 years. In this
ongoing study, there were 7 evaluations by the end of 2009.
The cognitive function of study participants was measured by the Community Screening
Interview for Dementia (CSID), at baseline and at years 3, 6, 9, 12, 15, and 17 with respect to
the baseline. The CSID questionnaire (Hall et al., 1996) has been widely used as a screening
tool for dementia. It evaluates multiple cognitive domains including language, attention,
memory, orientation, praxis, comprehension, and motor response. For this analysis, we use
a CSID score that incorporated all cognitive items from the screening exam some of which
had not been utilized previously (Hall et al., 1996). The additional cognitive score items in
the CSID include the East Boston story (immediate and delayed recall), 3 mental calculation
items, the name of the state, the name of the president, and the name of the governor. In
addition, unit weighting was used for object repetition, object recall, instruction command,
and animal naming, with the exception that animal naming is capped at a maximum raw
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score of 23 (95th percentile). The CSID total score ranges from 0 to 80, with higher scores
indicating better cognitive function.
Also, height and weight measures from all participants were collected at each evalua-
tion starting from year 3. Because obesity is associated with increased risk for diabetes,
hypertension and cardiovascular diseases, conditions related to increased risk of demen-
tia, it is therefore important to monitor weight change in this elderly cohort. It is widely
known that subjects with dementia and cognitive impairment suffer weight loss, which can
be attributed to the fact that these subjects often forget to eat. However, there are also
reports that weight loss precedes dementia diagnosis (Buchman et al., 2005). In particu-
lar, in this cohort, we found that accelerated weight loss was associated with dementia or
mild cognitive impairment (MCI) as early as 6 years prior to clinical diagnosis, supporting
the hypothesis that weight loss is an early marker for the manifestation of the dementia
disorder, including the early stage of MCI (Gao et al., 2011). It is important to examine
the longitudinal trajectories of both cognitive function and weight measures to determine
whether cognitive decline leads to weight loss or whether weight change proceeds cognitive
impairment. Because both body weight and cognitive function are assumed to be stable
over time and sudden changes may indicate underlying disease processes, we propose to
use bivariate change point models to model cognitive trajectories and changes in body mass
index (BMI) over time, with a particular focus on the correlation between the change points
of the two trajectories. Here, BMI is defined as weight in kilograms divided by height in
meters squared. We choose to use only two change points based on the study design of the
IIDS data. The IIDS followed normal subjects without dementia to dementia diagnosis and
no data were collected once a subject was diagnosed with dementia. Because both body
weight and cognitive function in elderly subjects without dementia are assumed to be stable
over time and sudden changes may indicate underlying dementia progression, we believe one
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change point for each longitudinal trajectory should capture the decline in the pre-dementia
or earlier dementia stage. It is possible that there exists a second change point, reflecting
a rapid deterioration in both body weight and cognition just prior to death. However, be-
cause the IIDS did not conduct any follow-up evaluations in the subjects with dementia and
our evaluation interval window of every 2 to 3 years may be too wide to capture the rapid
changes in the second change points, we focused on models with only one change point.
Out of the 2212 IIDS participants enrolled at baseline, 441 had at least 5 cognitive mea-
surements, of which 238 also had at least five BMI measurements. For modeling purposes,
we restrict the data to participants with at least 5 measurements for both of cognitive
function and BMI N = 238. Out of the 238 subjects with age ranges from 64.3 to 84.6
at baseline, 190 (79.8%) subjects were female. The mean baseline age was 70.4 (SD=4.8)
years old and the mean years of education was 10.8 (SD=2.6). The mean cognitive scores
at baseline and visit 6 were 70.6 (SD=6.0) and 65.4 (SD=9.6), respectively. BMI mea-
sures were collected starting from visit 1, and the mean BMI at visits 1 and 6 were 29.1
(SD=5.1) and 26.7 (SD=5.3), respectively. The histogram plots of cognitive function and
BMI measures at baseline were also explored. Although CSID scores are slightly skewed
toward lower scores, we assumed normal distributions for both CSID scores and BMI mea-
sures. We investigated the robustness of our proposed methods to non-normal distributions
in simulation studies. Figure 2.1 shows the cognitive and BMI trajectories from 5 randomly
selected IIDS participants. It can be seen from Figure 1 that, in general, both cognitive
score and BMI decrease with age. We noted that these 238 participants used in our analysis
are survivors with relatively long follow-up information and they expected to be healthier
than others in the cohort who did not provide five measurements. In Section 2.8, we provide
further discussion on the impact of missing data due to death and its potential impact on
our analysis results.
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Figure 2.1: Observed longitudinal cognitive scores and BMI measures over time for five
randomly selected participants from IIDS.
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2.4 Statistical Methods
In this section, we define notations and introduce the three different random change point
models for longitudinal outcomes. For each longitudinal outcome, we consider the random
change point model with one change point that can be further extended to multiple change
points. Let tij be the time of the j-th longitudinal measurement for the i-th subject,
i = 1, 2, ..., n, j = 1, 2, ...,mi; y1ij and y2ij are the bivariate longitudinal outcomes for the
i-th subject at time tij .
2.4.1 Broken-Stick Model
For the i-th subject at time tij ,
y1ij = α1i + α2i(tij − α4i)I(−∞,α4i)(tij) + α3i(tij − α4i)I[α4i,∞)(tij) + 1ij , (2.1)
y2ij = α5i + α6i(tij − α8i)I(−∞,α8i)(tij) + α7i(tij − α8i)I[α8i,∞)(tij) + 2ij, (2.2)
where α4i and α8i denote the change points for y1ij and y2ij , respectively. α1i and α5i
represent the intercepts in the two models and can be interpreted as the mean values
of longitudinal outcomes at change points α4i and α8i, respectively. α2i and α6i denote
the slopes before the change points, and α3i and α7i denote the slopes after the change
points. 1ij and 2ij denote the residual errors of the longitudinal measurements, which are
independently distributed as 1ij ∼iid N(0, σ2e1) and 2ij ∼iid N(0, σ2e2). IA(·) is an indicator
function with IA(x) = 1 for x ∈ A and IA(x) = 0 for x 6∈ A.
In addition, we assume a multivariate distribution for the parameters in model 2.1 and
2.2,
αi = (α1i, α2i, α3i, α4i, α5i, α6i, α7i, α8i)
T ∼ MVN(α,Σα),
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where α = (α1, α2, α3, α4, α5, α6, α7, α8)
T is a 8× 1 vector with each entry representing the
population mean, and Σα is the 8× 8 variance-covariance matrix.
The broken-stick model can be implemented using a Bayesian framework and has simple
parameter interpretation. However, it is not always appropriate because a sudden change in
direction may not be a realistic assumption. Furthermore, the non-continuity at the change
point can also cause numerical problems in parameter estimation using the frequentist
method, such as the maximum likelihood method. Thus, there is a need to investigate
other models not hampered by the disadvantages of the broken-stick model. Here, we use
some IIDS data analysis results from Section 2.6 as an example to illustrate the three
different models. In Figure 2.2, the black dots denote the cognitive function measures for a
randomly selected individual and the black solid line illustrates the predicted broken-stick
curve of this individual with a sudden transition happened at age of 78.13 years old.
2.4.2 Bacon-Watts Model
An alternative to the broken-stick model is the Bacon-Watts model (Bacon and Watts,
1971). For the i-th subject at time tij ,
y1ij = β1i + β2i(tij − β4i) + β3i(tij − β4i)trn((tij − β4i)/φ1) + 1ij , (2.3)
y2ij = β5i + β6i(tij − β8i) + β7i(tij − β8i)trn((tij − β8i)/φ2) + 2ij , (2.4)
where trn denotes the general transition function. Here, we choose to use the hyperbolic
tangent function, tanh, a commonly used transition function; φ1 and φ2 are the transi-
tion parameters in the bivariate model and determine transition rates with larger values
corresponding to slower transitions. In particular, if the transition parameter is close to
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Figure 2.2: Predicted curves of the three types of change point model for the cognitive
scores of an individual from IIDS.
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zero, the Bacon-Watts model will work similarly to the broken-stick model. Parameters
β1i and β5i denote the intercepts in each model, which have the same interpretation as in
the random broken-stick models. Parameters β4i and β8i are change points in the bivariate
model. However, the two slopes (β2i and β3i) in model 2.3 and the two slopes (β6i and β7i)
in model 2.4 no longer have the same interpretation as in the random broken-stick model
due to the formulation of the Bacon-Watts model. Again, we assume a multivariate normal
distribution for all parameters in the bivariate model,
βi = (β1i, β2i, β3i, β4i, β5i, β6i, β7i, β8i)
T ∼ MVN(β,Σβ),
where
β = (β1, β2, β3, β4, β5, β6, β7, β8)
T ,
is the vector of means, and Σβ is the 8× 8 variance-covariance matrix corresponding to the
parameter vector.
Compared to the broken-stick model, the Bacon-Watts model enjoys continuity over
the entire parameter space. However, its applicability may be limited because its slope
parameters are difficult to interpret with respect to practice. Continuing the previous
example in Section 2.4.1, the black dash line in Figure 2.2 shows the predicted Bacon-
Watts curve with a smooth transition at the age of 77.68 years and a transition parameter
of 1.60 for the selected subject.
2.4.3 Smooth Polynomial Model
Another alternative to the broken-stick model is the smooth polynomial model in which
the continuity in the regions around the change points is achieved by using a polynomial
function(van den Hout et al., 2010). The bivariate random smooth polynomial model for
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the i-th subject at time tij is given by
y1ij = (η1i + η2itij)I(−∞,η4i)(tij) + g1(tij |η1i, η2i, η3i, ε1)I[η4i,η4i+ε1)(tij)
+(λ1i + η3itij)I[η4i+ε1,∞)(tij) + 1ij (2.5)
and
y2ij = (η5i + η6itij)I(−∞,η8i)(tij) + g2(tij |η5i, η6i, η7i, ε2)I[η8i,η8i+ε2)(tij)
+(λ2i + η7itij)I[η8i+ε2,∞)(tij) + 2ij (2.6)
where ε1 and ε2 denote the intervals around the change points that connect the two linear
parts in each model and act as transition parameters as in the Bacon-Watts model but
with a slightly different interpretation. As the transition parameter tends to zero, the
interval around the change point tends to zero and the smooth polynomial model becomes
the broken-stick model. Note that the parameters in the smooth polynomial models have
different interpretations from the previous two models. The change points in the smooth
polynomial models are defined as η4i+1/2ε1 and η8i+1/2ε2, respectively. η1i and η5i are the
mean values of longitudinal measurements at η4i and η8i for the ith subject, respectively.
Parameters η2i and η3i specify the slopes for the two linear parts before and after the smooth
interval, respectively, for y1ij , and η6i and η7i are defined similarly for y2ij .
In model 2.5, λ1i is derived by assuming the equality of the two linear parts at change
point η4i + 1/2ε1; eventually it could be represented by a function of (η1i, η2i, η3i, ε1). λ2i
in model 2.6 is derived by following the same argument. Hence,
λ1i = η1i + η2i(η4i + 1/2ε1)− η3i(η4i + 1/2ε1),
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λ2i = η5i + η6i(η8i + 1/2ε2)− η7i(η8i + 1/2ε2).
g1 and g2 are two pre-specified polynomial functions that connect the two linear parts
in each model. As in van den Hout et al. (2010), the smoothness of transition is achieved
by imposing special constraints on g1 so that the polynomial function will connect with the
values of the linear function:
g1(η4i) = η1i + η2iη4i, g1(η4i + ε1) = η1i + η2i(η4i + ε1),
(
∂
tij
g1)(η4i) = η1i, (
∂
tij
g1)(η4i + ε1) = η2i.
By defining g1 as a cubic polynomial, g1(x) = a3x
3 +a2x
2 +a1x+a0, and solving the above
linear system of four linear ordinal differential equations, g1 is a quadratic polynomial with
the following coefficients (the coefficient of x3 is zero):
a2 =
η3i − η2i
2ε1
, a1 = η2i − η3i − η2i
ε1
η4i, a0 = η1i +
η3i − η2i
2ε1
η23i.
The form of g2 can be specified similarly as g1.
We again assume a multivariate normal distribution for all parameters in model 2.5 and
2.6:
ηi = (η1i, η2i, η3i, η4i, η5i, η6i, η7i, η8i)
T ∼ MVN(η,Ση),
where
η = (η1, η2, η3, η4, η5, η6, η7, η8)
T
represents the mean vector, and Ση is the 8 × 8 variance-covariance matrix corresponding
to the parameter vector.
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The smooth polynomial model not only maintains the advantages of the previous two
models but also overcomes drawbacks of the previous two models. Thus the smooth poly-
nomial model is superior in interpretable parameters and continuity at the change point.
Again, in Figure 2.2, assuming a fixed interval of 3 years around the change point, the
predicted smooth polynomial curve is illustrated (black dot line) for the selected individual.
It is observed that the smooth curve started at 80.51 years old and the change point was
at 82.01 years old, calculated by adding half of the interval (1.5 years) to 80.51.
2.4.4 Estimation Method
The maximum likelihood method is commonly used for parameter estimation in mixed-
effects models. However, its use in models with multiple random effects can be challenging
due to the need for multi-fold integrations. The Gaussian quadrature method, a numerical
technique for approximating the multi-fold integration in mixed-effects models, can become
computationally intractable when the number of random effects are large. In contrast, the
Bayesian method using MCMC sampling avoids the direct multi-fold integration by taking
repeated samplings from conditional posterior distribution for each parameter in the model,
thus providing numerical solutions to a complex modeling situation.
The Bayesian method has been considered by Hall et al. (2003), Dominicus et al. (2008),
van den Hout et al. (2010), and Hall et al. (2001) for parameter estimation from univariate
random change point models. WinBUGS (Lunn et al., 2000) is a powerful and flexible sta-
tistical software for Bayesian inference using the Gibbs sampling technique. BRugs (Ligges
et al., 2009) is a package in R (R Development Core Team, 2007) that also uses the Gibbs
sampling method for Bayesian inference. BRugs performs similarly as WinBUGS with an
additional advantage of combining data manipulation with the Bayesian model’s fitting
process including model specification and the choice of priors. We chose to implement our
18
methods using BRugs mostly because it can handle the simulations. For application to
data analysis, we expect both WinBUGS and BRugs will be adequate for implementing the
bivariate change point model.
The quality of fit is based on two criteria, the deviance information criterion (DIC)
(Spiegelhalter et al., 2002) and the conditional predictive ordinate (CPO) (Gelfand et al.,
1992). The trace plot of MCMC iterations is also monitored for purpose of convergence
checking. The DIC has been widely used for Bayesian model comparison. Dominicus et al.
(2008) used DIC to compare models with different structures as well as models differing
in prior distributions. The DIC consists of two parts: DIC = D¯ + pD, where D¯ is the
posterior expectation of deviance, and pD is the effective number of parameters measuring
the complexity of model (defined as the posterior mean of the deviance minus the deviance
of the posterior means). Similar to Akaike information criterion (AIC) (Akaike, 1987), a
smaller DIC corresponds to a better fit. Another frequently used model-selection criteria
in Bayesian inference is the CPO, a cross-validated predictive approach calculating the
predictive distributions conditioned on the observed data by leaving out one observation
each time. Chen et al. (2000) showed that there existed a Monte Carlo approximation of the
CPO. The models are compared using the log pseudo-marginal likelihood (LPML), which
is defined as LPML =
∑n
i=1 log(ĈPOi), where n is the total number of observations and
ĈPOi is the Monte Carlo approximation of CPO. Contrary to the DIC, the model with
larger LPML indicates a better fit.
2.5 Simulation Study
We used Monte Carlo (MC) simulations to assess the performance of the Bayesian approach
for parameter estimation in the proposed bivariate random smooth polynomial models be-
cause the smooth polynomial model is more realistic in practice and more comprehensive
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than the other two models. We simulated data from a bivariate random smooth polyno-
mial model using the estimated parameters from fitting this model to the real data (IIDS).
Specifically, each simulated MC data set consists of bivariate longitudinal data from 238
subjects with 7 non-missing bivariate repeated measurements per subject (equally spaced
with 3 years between the two adjacent visits). Baseline ages from IIDS subtracted by 65
years were used as ages at the first visit for each subject.
We present simulation results for 12 scenarios by varying the correlation between the
two change points, variances of change points and measurement errors (Table 2.1):
Table 2.1: Considered 12 simulation scenarios differing in correlation between two change
points (rη4η8), variance of each change point (σ
2
η4 , σ
2
η8) and variance of each measurement
error (σ21 , σ
2
2).
Scenario rη4η8 σ
2
η4 , σ
2
η8 σ
2
1 , σ
2
2
1 0.2 64, 16 20, 5
2 0.2 64, 16 5, 1
3 0.2 16, 4 20, 5
4 0.2 16, 4 5, 1
5 0.4 64, 16 20, 5
6 0.4 64, 16 5, 1
7 0.4 16, 4 20, 5
8 0.4 16, 4 5, 1
9 0.6 64, 16 20, 5
10 0.6 64, 16 5, 1
11 0.6 16, 4 20, 5
12 0.6 16, 4 5, 1
The other parameters were chosen to be close to the estimated parameters from IIDS
data: η1 = 70, σ
2
η1 = 15, η2 = −0.2, σ2η2 = 0.2, η3 = −3, σ2η3 = 2, η4 = 15, η5 = 28,
σ2η5 = 16, η6 = 0.2, σ
2
η6 = 0.2, η7 = −0.4, σ2η7 = 0.2, η8 = 10, rη2η3 = 0.2, rη6η7 = −0.5,
rη4η8 = 0.4, ε1 = 3, and ε2 = 3. Here, rη2η3 denoted the correlation between η2 and η3,
rη6η7 and rη4η8 were defined similarly. Thus, in the 8 by 8 variance-covariance matrix Ση,
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only ση2η3 , ση6η7 and ση4η8 were nonzero, and all the other off-diagonal elements were set
to be zeros.
2.5.1 Estimation Using Bivariate Random Smooth Polynomial Models
In the Bayesian model fitting of the bivariate random smooth polynomial model, prior
distributions of parameters for scenario 1 were chosen as the following:
η1 ∼ N(65, 0.01), η5 ∼ N(25, 0.01),
σ2η1 ∼ invGamma(0.001, 0.001), η2
η3
 ∼ N

 0
0
 ,
 0.01 0
0 0.01

 ,
Ση2η3 ∼ invWishart

 0.1 0
0 0.1
 , 2
 ,
 η4
η8
 ∼ N

 15
10
 ,
 0.01 0
0 0.01

 ,
Ση4η8 ∼ invWishart

 100 0
0 100
 , 2
 ,
(η6, η7)
T and Ση6η7 have the same prior distribution as (η2, η3)
T and Ση2η3 , respectively;
σ2η5 , σ
2
1 and σ
2
2 also have the same priors as σ
2
η1 . In Bayesian analysis, in particular,
conjugate prior is a natural and popular choice because of its flexibility and mathematical
convenience. invGamma(α, β) was chosen as it is commonly used as the conjugate prior
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to the variance of univariate normal distribution, where α is the shape parameter and β
is the scale parameter. On the other hand, invWishart(Σ, k) was a conjugate prior to
the variance-covariance matrix of a multivariate normal distribution, where Σ is a positive
definite inverse scale matrix and the positive integer k denotes the degree of freedom. Priors
for scenario 2 were chosen the same as in scenario 1 except the variance-covariance of the
two change points:
Ση4η8 ∼ invWishart

 10 0
0 10
 , 2
 .
The two transition parameters ε1 and ε2 were first treated as fixed (equal to the true
values) in the model fitting for the two scenarios. For each scenario, 500 MC samples
were generated and fitted by the bivariate random smooth polynomial model. For each
MC sample, 20, 000 additional iterations were considered following 2000 burn-in iterations.
The simulation results are presented in Table 2.2, 2.3, 2.4, 2.5, 2.6 and 2.7. For each
scenario, we reported mean, mean squared error, mean standard error, empirical standard
error, and coverage probabilities of 95% posterior intervals. The simulation results showed
that the Bayesian method generally performed well for fitting the bivariate smooth random
polynomial model: estimated parameters had low bias and coverage probability rates of
95% posterior credible intervals were around the nominal level. It is also observed that
model-fitting is influenced by the variances of change points and variance of measurement
errors. Specifically, smaller variances of change points or variance of measurement errors
led to parameter estimates with smaller bias, as well as smaller MSEs. We also conducted a
simulation study treating the two transition parameters as unknown parameters and setting
uniform prior distributions for them. The simulation results are presented in Table 2.8 and
2.9. We found few differences in parameter estimations between the two situations.
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2.5.2 Estimation Using Broken-Stick and Bacon-Watts Models
We have been focusing on investigating the performance of the bivariate random smooth
polynomial model via simulation studies. However, the random smooth polynomial model
is much more complex in model structure than the other two models, and consequently
more computationally expensive in practice; thus there is a need to study the performance
of the other two simplified bivariate models under the assumption that the true model is
the bivariate random smooth polynomial model.
Prior distributions for the bivariate random broken-stick model and the bivariate ran-
dom Bacon-Watts model were chosen similarly to that in the bivariate random smooth
polynomial model. The two transition parameters in the bivariate random Bacon-Watts
model were treated as unknown parameters with uniform prior distributions,
φ1 ∼ Unif(0.1, 5),
φ2 ∼ Unif(0.1, 5).
Table 2.10, 2.11, 2.12, 2.13, 2.14 and 2.15 summarized the simulation results of the three
different bivariate models for the 12 scenarios. Since most model parameters were not
directly comparable due to different model parameterizations, only the following parameters
were compared among the three bivariate models: change points, variances of change points,
and correlations between change points. Under the assumption that the true model is a
bivariate random smooth polynomial model, simulation results confirmed that the bivariate
random smooth polynomial model had the best performance among the three modeling
frameworks with smaller bias, smaller MSEs, and better posterior interval coverage. In
contrast, the bivariate random broken-stick model and the bivariate random Bacon-Watts
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model showed larger bias, larger MSEs and worse posterior interval coverage in parameter
estimations than those obtained under the bivariate random smooth polynomial model.
The bivariate random broken-stick model and the bivariate random Bacon-Watts model
had similar parameter estimation results. When the variances of random change points
were larger, the change points were underestimated by approximately two years; estimates
of variances of change points and correlation between change points also deviated from the
true values. However, when the variances of measurement error and variances of change
points were small, the bivariate random broken-stick model and the bivariate random Bacon-
Watts model had much improved performance, nearly as well as the bivariate random
smooth polynomial model.
2.5.3 Sensitivity Analysis
Estimation of change point of random change point model is usually sensitive to the distri-
butional assumption of the data. To study the sensitivity and robustness of the proposed
methods, we replaced the normal distribution in generating the simulated data for random
effects and error density by lognormal distributions. Again, for each scenario, 500 Monte
Carlo samples, each with 238 subjects and 7 non-missing bivariate repeated measurements
per subject, were generated from the bivariate random smooth polynomial model with cor-
related slopes in each univariate model. The true parameters were selected to be the same
as those in the previous simulation study, and then transformed to the mean and standard
deviations of the lognormal distribution to ensure the generated data have the similar range
as when using normal distributions. The generated MC samples were then fitted by the 3
bivariate change point models assuming normal distributions of the random effect and error
terms. The prior distributions for parameters for each model were chosen in similar fashion
as in the previous section. For each MC sample, 20, 000 additional iterations were consid-
24
ered following 2000 burn-in iterations. Simulation results, including the estimates of change
points, variances of change points, and the correlation estimates between change points are
presented in Table 2.16. The results show that for both of the small and large scenario the
bivariate random smooth polynomial model has the best performance in smaller MSE and
better 95% PI coverage. It is also observed that under the assumption of the lognormal dis-
tribution and the smooth polynomial model, the bivariate random broken-stick model and
the bivariate Bacon-Watts model are sensitive in estimating change points. In addition, the
variance of change points and measurement errors have some impact on the model-fitting
results. Specifically, the change point estimates from the small variance scenario are less
sensitive than those from the large variance scenario.
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2.6 Application to the IIDS Data
In this section, the three proposed models are fitted to the IIDS data using the previously
described Bayesian method. Specifically, age was centered at 65 years. For each bivariate
model, we consider two different models that differ in the variance-covariance structure.
Of particular interest is the relationship between the change points of cognitive and BMI
measurements, and we assume that cognitive function and BMI are correlated only through
their change points.
For bivariate random broken-stick models, we denote by BS1 the model with the follow-
ing specified variance-covariance structure:
Σα =

σ2α1 0 0 0 0 0 0 0
0 σ2α2 σα2α3 0 0 0 0 0
0 σα2α3 σ
2
α3 0 0 0 0 0
0 0 0 σ2α4 0 0 0 σα4α8
0 0 0 0 σ2α5 0 0 0
0 0 0 0 0 σ2α6 σα6α7 0
0 0 0 0 0 σα6α7 σ
2
α7 0
0 0 0 σα4α8 0 0 0 σ
2
α8

.
This model allows correlations between the slopes before and after the change points. Model
BS2 is further defined by setting σα2α3 = 0 and σα6α7 = 0, without correlations between the
two slopes. Bayesian estimation for the above two models were obtained by imposing prior
distributions similar to those in the simulation study. We found that the choice of non-
informative prior distributions had little influence on the marginal posterior distributions.
41
Model BS1 (DIC = 15, 810,LPML = −6, 752) is superior to BS2 (DIC = 15, 820,LPML =
−6, 766) in terms of smaller DIC, larger LPML, and better convergence based on the history
trace plots of model parameters. Table 4 shows the summary statistics of the posterior
distributions of model parameters from model BS1. The mean (95% posterior interval) age
of cognitive function change point is 22.7 (19.5, 25.7) years; the mean slope before change
point is −0.1 (−0.2,−0.1) points/year, and the mean slope after change point is −1.7
(−2.6,−1.0) points/year. Cognitive function decreases steadily before the change point and
plummets after the change point. On the other hand, for BMI the mean age of change point
is 12.5 (9.0, 16.8) years; the mean slope before the change point is 0.2 (0.03, 0.4) points/year,
and the mean slope after the change point is −0.4 (−0.6,−0.3) points/year. BMI steadily
increases before its change point and decreases after. The posterior means of correlation
between the 2 slopes for cognitive function and BMI are both positive but with wide 95%
posterior intervals. The posterior mean of the correlation between the 2 change points is 0.5
(0.1, 0.8), suggesting that the change in cognitive function is positively correlated with the
change in BMI. Furthermore, the estimated change point of BMI is found to be on average
10 years ahead of the estimated change point of cognitive function. The posterior means of
the variances of the change points of cognitive function and BMI are 52.3 (30.5, 82.8) and
22.5 (9.0, 43.6), respectively.
For the bivariate random Bacon-Watts model, we denote by BW1 the model with the
same variance-covariance structure as for BS1, and by BW2 the model with the same
variance-covariance structure as for BS2 above. Prior distributions are chosen to be similar
to the settings for the bivariate random Bacon-Watts model in the simulation study. Differ-
ent prior distributions led to similar posterior distributions of model parameters, DIC and
LPML. The two slopes in each model are correlated according to the model parameteriza-
tion of the random Bacon-Watts model. Therefore BW1 as a more faithful model should
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be a better model than BW2. This is evident from the history trace plots of model parame-
ters, the DIC, and LPML. Specifically, the BW1 had a smaller DIC 15, 790 vs. 15, 870 from
model BW2, and a greater LPML −6, 738 vs. −6, 806 from model BW2. The posterior dis-
tributions of model parameters for model BW1 is summarized in Table 3. The mean change
points for cognitive function and the BMI are 22.1 (18.8, 25.5) and 11.3 (7.9, 15.3) years,
respectively. The posterior mean of transition parameters φ1 and φ2 are 1.7 (0.2, 4.4) and
3.3 (0.4, 4.9), respectively. The posterior mean of change point correlation is 0.5 (0.1, 0.8),
confirming that change in cognitive function is positively correlated with change in BMI.
Similar to the previous model BS1, the estimated change point of BMI is around 11 years
ahead of the estimated change point of cognitive function.
Again, for the bivariate random smooth polynomial model, model SP1 enjoys the same
variance-covariance structure as for BS1, and model SP2 has the same variance-covariance
structure as for BS2. The prior distributions for parameters in the above two models are
specified similarly as in the simulation study. Different from the bivariate random Bacon-
Watts model, the transition parameters in the smooth polynomial model are held constant
at 3 years, according to the roughly 3 year intervals between two visits. We assume that the
change of cognitive function and BMI occurred within 3 years (we also implemented model
fitting with the two transition parameters equal to 1 or 6 years, but parameter estimates
are quite similar). Due to the limited number of repeated measurements per subject, we
choose not to include those parameters in the model. This also resulted in a convergence
problem in the Bayesian computation. Model SP1 is superior with a smaller DIC of 15, 540
(compared to Model SP′2s 15, 720), and a larger LPML of −6, 659 (compared to Model SP′2s
−6, 742), as well as better convergence profiles, as is evident from the history trace plot.
Table 5 shows a summary of the posterior distributions of model parameters for model SP1.
The mean age of cognitive function change point is 27.5 (= 26.0 + 1.5) (22.3, 30.8) years
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with variance 60.8 (33.5, 105.6); the mean slope before smooth interval is −0.2 (−0.2,−0.1)
points/year, and the mean slope after smooth interval is −2.99 (−4.8,−1.67) points/year.
Cognitive function steadily decreases before the smooth interval and sharply declines after.
For BMI measurement, the mean age of BMI change point is 11.0 (= 9.5 + 1.5) (7.3, 12.4)
years with variance 14.5 (8.0, 23.9); the mean slope before the smooth interval is 0.2 (0.1, 0.4)
points/year, and the mean slope after the smooth interval is −0.4 (−0.5,−0.3) points/year.
The BMI has a similar trend - gradually increasing before smooth interval and decreasing
after. The posterior mean of change point correlation is 0.6 (0.2, 0.8), which again implies
that change in cognitive function is positively correlated with the change in BMI. Compared
with the change point of cognitive function, the change point of BMI appears to be 16 years
ahead on average.
The model fitting of the three bivariate models uses the same 10,000 burn-in and 40,000
additional iterations. It takes about 20 minutes, 27 minutes, and 55 minutes for the bivariate
random broken-stick, the bivariate random Bacon-Watts and the bivariate random smooth
polynomial model, respectively, in a PC with Pentium(R) 4 CPU 2.00 GB of RAM.
In the previous paragraphs, we have presented model-fitting results of the 3 different bi-
variate random change point models for cognitive function and BMI. The fitted trajectories
of nine random selected individuals from IIDS for models BS1, BW1, and SP1 are shown
in Figure 2.3. The three models were compared based on both DIC and LPML; model SP1
appears to be the best model under consideration of the smallest DIC (15, 540) and the
largest LPML (−6, 659). Differences in parameter estimation among the three models were
observed (Table 2.17). The estimated change points of cognitive function measurements
are 22.7, 22.1, and 27.5 years for model BS1, BW1, and SP1, respectively. The estimated
change points of models BS1 and BW1 are very close, while the estimated change point of
cognitive function of SP1 is around 5 years later than those from the other two models.
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Various reasons may cause such a big change point estimate for cognitive function in the
random smooth polynomial model. First, as we have observed in scenario 1 of the simula-
tion study, if the true model is the bivariate random smooth polynomial model with larger
variances, the estimated change points tends to be years later than the other two models.
Secondly, the special model structure of the smooth polynomial model (with an additional
smooth interval between two linear trends) allows the seeking of change points in a later
time window. This is observed in the individual trajectory plot as well. On the other hand,
estimated change points for BMI in three models are comparable, which are all around 12
years (12.5, 11.3, and 11.0 years for model BS1, BW1, and SP1, respectively). This may be
because the BMI increases first and decreases later making it easy to detect a change point
for change point models. Another possibility is that the variance of measurement error and
variance of change point are both much smaller compared to the cognitive function, so the
estimation of change point of BMI becomes more stable for different models. The estimated
correlation between the change points of cognitive function and BMI in the 3 joint models
are similar(rα4α8 = 0.5, rβ4β8 = 0.5 and rη4η8 = 0.6 ), and all of them have good 95%
posterior interval coverage.
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Figure 2.3: Plots of nine random selected participants from IIDS (black circle), fit for
bivariate random broken-stick model BS1 (solid gray line), bivariate random Bacon-Watts
model BW1 (dashed black line) and bivariate random smooth polynomial model SP1 (solid
black line). The three fitted curves on the top are for cognitive scores, and the three fitted
curves on the bottom are for BMI measures.
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Table 2.17: Bayesian estimates of population parameters and 95% Posterior Interval (95%
PI) for bivariate random broken-stick model (BS1), bivariate random Bacon-Watts model
(BW1) and bivariate random smooth polynomial model (SP1) from IIDS data.
broken-stick model Bacon-Watts model smooth polynomial model
BS1 BW1 SP1
Para. Est. 95% PI Para. Est. 95% PI Para. Est. 95% PI
α1 68.6 (67.4, 69.7) β1 68.5 (67.4, 69.7) η1 71.4 (70.6, 72.1)
σ2α1 14.8 (10.8, 19.4) σ
2
β1
14.7 (10.7, 19.3) σ2η1 15.1 (11.3, 19.5)
α2 -0.1 (-0.2, -0.1) β2 -0.9 (-1.3, -0.5) η2 -0.2 (-0.2, -0.1)
σ2α2 0.02 (0.01, 0.03) σ
2
β2
0.4 (0.1, 1.0) σ2η2 0.04 (0.02, 0.1)
α3 -1.7 (-2.6, -1.0) β3 -0.7 (-1.2, -0.4) η3 -3.0 (-4.8, -1.7)
σ2α3 1.8 (0.6, 3.9) σ
2
β3
0.4 (0.12, 1.0) σ2η3 3.5 (0.9, 8.1)
α4 22.7 (19.5, 25.7) β4 22.1 (18.8, 25.5) η4 26.0 (22.3, 30.8)
η4 + 1/2ε1 27.5
σ2α4 52.3 (30.5, 82.8) σ
2
β4
51.4 (27.8, 83.0) σ2η4 60.8 (33.5, 105.6)
α5 30.8 (29.9, 31.7) β5 30.7 (29.8, 31.6) η5 28.6 (27.7, 29.5)
σ2α5 25.9 (21.1, 31.7) σ
2
β5
26.1 (21.2, 32.0) σ2η5 15.9 (11.9, 20.6)
α6 0.2 (0.03, 0.4) β6 -0.9 (-0.2, 0.1) η6 0.2 (0.1, 0.4)
σ2α6 0.03 (0.01, 0.1) σ
2
β6
0.03 (0.01, 0.05) σ2η6 0.2 (0.1, 0.3)
α7 -0.4 (-0.6, -0.3) β7 -0.3 (-0.4, -0.2) η7 -0.4 (-0.5, -0.3)
σ2α7 0.1 (0.04, 0.1) σ
2
β7
0.04 (0.01, 0.1) σ2η7 0.1 (0.1, 0.2)
α8 12.5 (9.0, 16.8) β8 11.3 (7.9, 15.3) η8 9.5 (7.3, 12.4)
η8 + 1/2ε2 11.0
σ2α8 22.5 (9.0, 43.6) σ
2
β8
18.4 (8.5, 36.1) σ2η8 14.5 (8.0, 23.9)
rα4α8 0.5 (0.1, 0.8) rβ4β8 0.5 (0.1, 0.8) rη4η8 0.6 (0.2, 0.8)
σ21 20.1 (18.4, 21.9) σ
2
1 20.0 (18.3, 21.9) σ
2
1 20.0 (18.3, 21.7)
σ22 5.8 (5.2, 6.4) σ
2
2 5.7 (5.0, 6.4) σ
2
2 5.0 (4.5, 5.6)
rα2α3 0.04 (-0.6, 0.6) rβ2β3 1.0 (0.9, 1.0) rη2η3 0.1 (-0.7, 0.8)
rα6α7 0.1 (-0.65, 0.7) rβ6β7 0.2 (-0.5, 0.7) rη6η7 -0.9 (-1.0, -0.8)
Φ1 1.7 (0.2, 4.4)
Φ2 3.3 (0.4, 4.9)
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2.7 Conclusion
We have developed joint modeling frameworks of bivariate longitudinal outcomes under
three different bivariate random change point models: the bivariate random broken-stick
model, the bivariate random Bacon-Watts model, and the bivariate random smooth poly-
nomial model. The proposed methodology was applied to the IIDS data. The Bayesian
method was used for model fitting using the BRugs package in R. The goodness of model
fitting was assessed using DIC and LPML.
The Bayesian method has been a useful tool for parameter estimation of mixed-effects
models with several advantages compared to traditional frequentist methods. First, the
highly complex model structure can be still easily handled in WinBUGS and BRugs. Sec-
ond, the Bayesian method can deal with the mixed-effect model with multiple random
effects. The maximum likelihood method using Gaussian quadrature is commonly used for
parameter estimation in non-linear mixed-effect models, but computation of multi-fold inte-
grations can become intractable with large number of random effects. Third, the Bayesian
method is also advantageous in its interpretability and ability to deal with missing data
(van den Hout et al., 2010). Finally, from a practical implementation perspective, the
Bayesian method using an MCMC sampling method is conveniently available in various
popular statistical software, such as WinBUGS and BRugs in R. The often cited disadvan-
tage of heavy computation overhead of Bayesian MCMC has become less an issue with the
rapid advances of modern computing technology. Bayesian methods require one to specify
the prior distributions, which sometimes may be challenging. In many cases, knowledge of
priors of parameters is either unknown, or even non-existent, which makes it very difficult
to specify a unique prior distribution. Careful sensitivity analysis is needed to assess the
influence of different priors on the posterior estimates. In our analysis, it appears that
the model-fitting results are not sensitive to the choices of priors. On the other hand, the
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Bayesian method is a useful technique that can incorporate available prior knowledge of the
model parameters into the prior distributions.
The restriction of subjects with at least 5 measurements to be included in our analysis
makes the models conditional on the subjects having to survive to a relatively long period of
time during follow-up and inevitably limits the modeling to a subset of healthier individuals
than the rest of the cohort. It is known that missing data, especially under the non-ignorable
missing data mechanism, could significantly impact model results. In the IIDS data and in
most longitudinal studies involving elderly subjects, subject dropouts due to death account
for the majority of missing data. Our current proposed method is limited in its capability
to deal with non-ignorable missing data and also in the ability to detect potential change
point, followed by rapid death. Ghosh et al. recently studied the effect of informative
dropouts in longitudinal outcomes with multiple change points (Ghosh et al., 2010). It
will be an important future research topic to study bivariate change point models that
incorporate informative dropouts so that inference on the entire longitudinal cohort can be
made. Another interesting and important future research is to take censored change points
into account in the bivariate change point model.
The proposed bivariate random change point models not only estimate the change points
of bivariate longitudinal outcomes, but also investigate the correlation between the change
points. The bivariate random broken-stick model has the advantages of easy implementa-
tion and interpretable parameter estimation but the non-continuity at change points may
result in numeric problems. The bivariate random Bacon-Watts model solves the problem
of non-continuity at change points but the parameter estimation loses meaningful interpre-
tations. The bivariate random smooth polynomial model ensures the continuity at change
points and meaningful parameter interpretations, but at a cost of more complex model
structures. These methodologies are useful for disease prognosis using biomarkers in medi-
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cal science, and it also possesses flexibility in model fitting. Although in this paper we have
focused on investigating the correlation between the change points, one can readily extend
to more complex models by specifying and estimating other correlation parameters such as
correlation between the two slopes before the change point as well as the two slopes after
the change point in the bivariate model. The extension to multivariate change point models
for multiple longitudinal outcomes is also applicable.
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Chapter 3
Joint Models for Multiple Longitudinal Processes and Time-to-event Outcome
3.1 Abstract
Joint models are useful tools to study the association between time-to-event and longitu-
dinal outcomes. Common estimation methods for joint models include two-stage, Bayesian
and maximum-likelihood methods. In this work, we extend existing methods and develop
a maximum-likelihood estimation method using the expectation-maximization (EM) algo-
rithm for joint models of a time-to-event outcome and multiple longitudinal processes. We
assess the performance of the proposed method via simulations and apply the methodology
to a data set to assess the association between longitudinal systolic and diastolic blood
pressure (BP) measures and time to coronary artery disease (CAD).
3.2 Introduction
Prospective cohort studies or clinical trials with time-to-event as the primary outcome usu-
ally collect many longitudinal variables. Longitudinal studies of Alzheimer’s disease, for
example also collect repeated measures of height, weight, BP measures and many other
variables in order to determine disease etiology (Yang and Gao, 2012). Clinical trials on
cardiovascular diseases routinely monitor BP measures at regular intervals to ensure patient
safety (Rothwell et al., 2010). In addition, the increasing use of electronic medical records
(EMR) in many health care systems makes the collection of many longitudinal laboratory
measures as well as time to medical events automatic and straightforward. Separate model-
ing of the longitudinal processes and the survival outcome may not fully discover potential
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disease mechanisms. Appropriate statistical methods are needed to utilize the richness of
these data in order to identify potential relationships between the longitudinal measures
and disease risk.
Before the introduction of joint models, routine statistical practices in epidemiologic
research mostly adopted the Cox model (Cox, 1972) using baseline exposure measures. Such
an approach implicitly assumes that the exposure variables stay constant over the length of
the study, which is unlikely to be true in studies over an extensive period of time. Cox model
with observed longitudinal measures as time-dependent covariates (Andersen et al., 1993;
Andersen and Gill, 1982; Fleming and Harrington, 1991) incorporates changes in exposure
levels over the follow-up period. However, this model assume that the longitudinal outcomes
are continuously measured without errors. This assumption may not be realistic because
the longitudinal measures are usually intermittently collected. Furthermore, measurement
errors in the longitudinal measurements were not considered in this modeling framework.
Lastly, the time-dependent Cox model lacks the flexibility to use various functional forms
of the underlying longitudinal processes.
To overcome these difficulties, joint models of longitudinal and survival outcomes were
proposed by Faucett and Thomas (1996) and Wulfsohn and Tsiatis (1997). They used a
linear growth curve model for the longitudinal process and a Cox model with the current
value of the longitudinal process as time-dependent covariate. Many extensions to these
earlier joint models have been proposed. Henderson et al. (2000) modeled the hazard as a
function of the history and rate of change of a biomarker. Brown et al. (2005) extended
the linear growth curve model to flexible non-parametric subject-specific random-effects
models. Yu et al. (2004) considered a survival-cure model for the time-to-event outcome.
Huang et al. (2011) and Elashoff et al. (2008) extended the Cox model to competing risks
models. Elashoff et al. (2006) extended the joint models from a single survival outcome
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to multiple survival outcomes. Njeru Njagi et al. (2013) considered combining conjugate
and normal random effects of longitudinal and time-to-event outcomes in joint models to
improve model fit. Qiu et al. (2013) considered a generalized linear mixed model for the
longitudinal outcome and a discrete survival model with frailty to predict event probabilities.
Comprehensive reviews of joint models have been published (Proust-Lima et al., 2012; Sousa,
2011; Tsiatis and Davidian, 2004; Yu et al., 2004).
When multiple longitudinal measures are available, extension to the joint model frame-
work needs to appropriately account for potential correlations among the longitudinal mea-
sures. Simultaneous modeling of multiple longitudinal outcomes in joint models offers a
number of advantages over separate modeling of each longitudinal outcome (Brown et al.,
2005; Elashoff et al., 2006; Rizopoulos and Ghosh, 2011; Song et al., 2002; Xu and Zeger,
2001). First, for correlated longitudinal outcomes it is more relevant to estimate the ad-
justed association of each longitudinal outcome with the event risk (Rizopoulos and Ghosh,
2011). Second, Fieuws et al. showed that accounting for the correlation between longi-
tudinal measures may substantially enhance the predictive ability of joint models (Fieuws
et al., 2008). In addition, two studies found that joint models of multiple longitudinal out-
comes are more efficient compared with separate modeling of each outcome in some settings
(Gueorguiva and Sanacora, 2006; McCulloch, 2008).
There are three general types of estimation methods in joint models of longitudinal and
survival outcomes: the two-stage approach, Bayesian Markov Chain Monte Carlo (MCMC)
method, and maximum-likelihood approach. In the two-stage approach, parameter estima-
tion is conducted separately for the longitudinal model and the survival model. Specifically,
at the first stage, parameter estimates and predictions are obtained from the longitudinal
models without consideration of the survival outcomes. At the second stage, the pre-
dicted longitudinal values are used as true exposure levels in a time-dependent Cox model.
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Although the two-stage approach is computationally simple, it can incur bias and loss of
efficiency by ignoring the time-to-event information when modeling the longitudinal process
Albert and Shih (2010); Faucett and Thomas (1996); Sweeting and Thompson (2011), as the
survival process in this setting essentially produces non-ignorable missing data for the lon-
gitudinal outcomes. The two-stage approach has been discussed by many authors (Albert
and Shih, 2010; Dafni and Tsiatis, 1998; Self and Pawitan, 1992; Sweeting and Thomp-
son, 2011; Tsiatis et al., 1995; Ye et al., 2006). Alternatively, both the Bayesian MCMC
approach and the maximum-likelihood approach incorporate both types of outcomes into
a joint likelihood function and simultaneously estimate model parameters. The Bayesian
MCMC approach has been used for joint models of multiple longitudinal and time-to-event
outcomes (Brown and Ibrahim, 2003; Brown et al., 2005; Elashoff et al., 2006; He and Luo,
2013; Rizopoulos and Ghosh, 2011). To the best of our knowledge, the maximum-likelihood
method has only been applied to the joint models with a single longitudinal outcome (Huang
et al., 2011; Rizopoulos, 2012a; Tseng et al., 2005; Tsiatis and Davidian, 2004; Wulfsohn
and Tsiatis, 1997). In particular, Rizopoulos developed an R package (JM) using the EM
algorithm (Dempster et al., 1977) for joint models of a time-to-event outcome and a single
longitudinal outcome (Rizopoulos, 2010, 2012b).
In this work, we develop a maximum-likelihood approach using the EM algorithm for
parameter estimation in joint models of multiple longitudinal processes and a time-to-event
outcome. Commonly used for maximum-likelihood estimation, the EM algorithm offers
computational advantages over direct likelihood maximization (Couvreur, Couvreur) espe-
cially in complex likelihood functions involving random effects. The algorithm increases
the likelihood function as iteration continues, ensuring numerical stability. Additional ef-
ficiency can be gained when some parameters have closed-form solutions in the M-step.
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Finally, predicted values are calculated as part of the E-step reducing the need for further
computation.
The remainder of this chapter is organized as follows: Section 3.3 describes a primary
care patient cohort, a motivating example. Section 3.4 covers the joint models as well as the
joint likelihood function. The EM algorithm estimation method and asymptotic inferences
of maximum-likelihood parameter estimates are described in Section 3.5. Section 3.6 reports
the simulation studies. In Section 3.7 the proposed method is illustrated using a primary
care patient cohort data. Finally the chapter is concluded with a discussion in Section 3.8.
3.3 A Primary Care Patient Cohort
A primary care patient cohort was assembled in 1991 as part of depression screening in
primary care clinics in Wishard Health Service. From 1991 to 1993, patients age 60 years
or older in the Wishard Health Service were consented for depression screening during their
regular clinical visits to their primary care physicians. A total of 4,413 primary care patients
were initially contacted, of whom 115 refused; 57 were not eligible due to severe cognitive
impairment; 284 were not eligible because they were non-English speaking, in prison, in
a nursing home, or had a hearing impairment; 3,957 patients were enrolled in the study.
Details about the study have been published in Callahan et al. (1994) and Callahan et al.
(1994).
Complete EMR data are available for all enrolled patients and the information includes
diagnosis of medical conditions, BP measures, laboratory test measures and medications
order and dispensing. One of the research interests using data from this cohort is to examine
new risk factors for coronary artery disease (CAD) in elderly population. It is well known
from the results of prospective cohort studies that high baseline BP is a risk factor for CAD
in middle-aged populations (Anderson et al., 1991; Stamler et al., 1993; Wilson et al., 1998),
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but few studies have determined the relationship between longitudinal BP measures and
the risk of CAD. Even fewer focused on the elderly population who have declining BP with
increasing age. Therefore, it is necessary to apply joint models to determine the association
between the longitudinal BP measures and risk of CAD in this elderly cohort.
Among the 3,957 patients enrolled, 2,654 (797 males and 1857 females) were free of
CAD at enrollment. For patients with incident CAD events, the date of diagnosis was
used as the event time; for patients without CAD, the last outpatient clinic visit before
December 31, 2010 was used as the censoring time. Systolic and diastolic BP measured in
sitting position from outpatient clinic visits were also collected during follow-up for up to
20 years. Since it has been shown that males have significantly increased CAD risk than
females (Hochman et al., 1999; Vaccarino et al., 1999), we focus our analysis on the 797
male patients in the cohort where 28% had incident CAD during the follow-up period from
enrollment to December 31, 2010. Mean age of patients included in the analysis sample at
baseline was 68 (SD=7.4) years, 519 (65.1%) were black, 254 (31.9%) were smokers, and 268
(33.6%) had history of diabetes at baseline. The frequency of BP measurements varied from
patient to patient with a mean frequency of 20.5 (SD=20). For computational convenience
annualized systolic and diastolic BP measures during the study period were derived for each
participant. On average, there were about 5.3 (SD=4.4) BP measures per subject. Figure
3.1 plots the annualized longitudinal systolic and diastolic BP measures over time by CAD
status. The blue and green curves represent fitted population mean BP profiles for CAD
and non-CAD groups respectively, using linear mixed-effects models with fixed quadratic
time effect. It can be seen that the population mean systolic and diastolic BP measures
were higher over time for the CAD group than that for the non-CAD group, indicating a
potential association between the risk of CAD and longitudinal systolic and diastolic BP
measures. The figure also shows that the differences in BP measures at baseline between the
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Figure 3.1: Observed annualized longitudinal systolic and diastolic BP measures over time
and fitted population mean curves for the CAD and non-CAD group.
CAD and non-CAD groups were negligible. Thus analyses relying on baseline BP measures
may not be able to detect any relationship between BP measures and risk of CAD.
3.4 Joint Models
In this section, we introduce joint models for multiple longitudinal processes and a time-to-
event outcome by defining the notations and formulation of the longitudinal and survival
models. Specifically, we consider multivariate mixed-effects models for the multiple longi-
tudinal outcomes and a Cox model for the time-to-event outcome with predicted functions
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of the longitudinal measures as time-dependent covariates. We then derive the likelihood
function of the joint models.
3.4.1 Longitudinal Models
Let yl(tij) denote the observed measurement of the l-th longitudinal outcome for subject i at
time points tij , where i = 1, ..., n, j = 1, ..., ni, l = 1, ..., L. The corresponding longitudinal
trajectory is modeled using the following model
yl(ti) = y
∗
l (ti) + il,
= XTl (ti)βl + Z
T
l (ti)bil + il (3.1)
where y∗l (ti) = (yl(ti1), yl(ti2), ..., yl(tini))
T is the corresponding true underlying longitu-
dinal measures of the l-th biomarker for the i-th subject; XTl (ti) is the design matrix of
fixed effects, including time effects and baseline covariates; βl is the corresponding vector
of the fixed effects; ZTl (ti) is the design matrix for the random effects, bil, distributed as
bi = (bi1,bi2, ...,biL)
T ∼ N(0,D); il is the corresponding measurement error term such
that il ∼iid N(0, σ2l Ini). It is worth noting that the correlations among the multiple lon-
gitudinal processes and the within-subject correlation for each longitudinal biomarker are
represented in the variance-covariance matrix of random effects D. We assume that the
measurement errors of different longitudinal outcomes are independent of each other, and
they are also independent of the random effects bi.
3.4.2 The Survival Model
Let T ∗i and Ci be the true event time and censoring time respectively for subject i. We
define the observed event time Ti = min(T
∗
i , Ci) and the event indicator δi = I(T
∗
i ≤ Ci).
Assuming that the hazard function depends on some functions of the true longitudinal
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measures F(y∗il(t)) and baseline covariates wi, the hazard function can be written as
hi(t) = h0(t) exp
{
γTwi +
L∑
l=1
αlF(y∗il(t))
}
, (3.2)
where h0(t) denotes the baseline hazard function, and αl and γ are coefficients for the
function of lth biomarker and baseline risk factors. The baseline hazard function can be a
parametric function or a flexible piecewise constant function. In this work, αl, l = 1, 2, ..., L,
are of primary interest. The correlation between the multiple longitudinal biomarkers and
the time-to-event outcome is induced by the shared random effects through y∗il(t) or bil in
the longitudinal and survival models.
The function F(·) can be chosen as different functional forms depending on the interest
of the study. For example, if the focus is the association between longitudinal values and
event risk, F(·) can be an identity function; if the change in the longitudinal measures is
of interest, F(·) can be chosen as derivative function with respect to time t; for studies
interested in the cumulative history of the longitudinal measures over time and event risk,
F(·) can be an integration function of y∗il(t) over time t. Depending on the choices, random
effects bi may affect the hazard function in a non-linear fashion. This is in contrast with
the frailty type of joint models where the random effects are linear in the exponential term
of the hazard.
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3.4.3 Joint Likelihood Function
Under the conditional independence assumption between bi and i the kernel of the joint
likelihood function is
L(θ) =
n∏
i=1
p(Ti, δi,yi1, ...,yiL|θ)
=
n∏
i=1
∫
p(Ti, δi|θ,bi)p(yi1|θ,bi) · · · p(yiL|θ,bi)p(bi|θ)dbi,
where θ = (γ,α,θh0 ,β,σ,D)
T is the vector containing all parameters in the models. Under
the assumed models (3.1) and (3.2) for the longitudinal and survival outcomes, there are
three components:
p(Ti, δi|θ, bi) =
{
h0(Ti) exp
(
wTi γ +
L∑
l=1
αlF
(
XTl (Ti)βl + Z
T
l (Ti)bil
))}δi
exp
{
−
∫ Ti
0
h0(u) exp
(
wTi γ +
L∑
l=1
αlF
(
XTl (u)βl + Z
T
l (u)bil
))
du
}
,
p(yi1|θ,bi) · · · p(yiL|θ,bi)
=
L∏
l=1
 1√
2piσ2l
ni exp
− 12σ2l
ni∑
j=1
(
yl(tij)−
(
XTl (tij)βl + Z
T
l (tij)bil
))2 ,
and
p(bi|θ) =
(
1√
2pi
)k/2
|D|−1/2 exp
(
−1
2
bTi D
−1bi
)
,
where k is the dimension of the D matrix.
3.5 Estimation Method
In this section, we present the maximum-likelihood method based on the EM algorithm for
parameter estimation and inference.
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3.5.1 Implementing the EM Algorithm
The complete log likelihood function given the random effects bi is:
logLC =
n∑
i=1
{
log p(Ti, δi|bi;θ) + log p(yi1|bi;θ) + ...+ log p(yiL|bi;θ)
+ log p(bi;θ)
}
.
In the E-step the expected complete log-likelihood function given the conditional distri-
bution of random effects is
Q(θ|θm) =
n∑
i=1
∫ {
log p(Ti, δi|bi;θ) + log p(yi1|bi;θ) + ...+ log p(yiL|bi;θ)
+ log p(bi;θ)
}
p(bi|Ti, δi,yi1, ...,yiL;θm)dbi.
For the M-step, close forms are available for the variance of residuals of each longitudi-
nal model and variance-covariance matrix of the random effects, whereas the fixed effects
for each longitudinal model and parameters in the survival model have to be estimated
numerically. The key steps are:
1. Estimation of the variance of residuals of each longitudinal model by
σˆl
2 =
1∑n
i=1 ni
n∑
i=1
(
yil −XTilβml
)T(
yil −XTilβml − 2ZTilE(bi|Ti, δi,yi1, ...,yiL;θm)
)
+Tr
(
ZTilZilVar(bi|Ti, δi,yi1, ...,yiL;θm)
)
+E(bi|Ti, δi,yi1, ...,yiL;θm)TZTilZilE(bi|Ti, δi,yi1, ...,yiL;θm)
where l = 1, ..., L, Tr represents the trace function of a matrix, and E denotes the
expectation function.
61
2. Estimation of variance-covariance matrix of random effects by
Dˆ =
1∑n
i=1 ni
n∑
i=1
Var(bi|Ti, δi,yi1, ...,yiL;θm)
+E(bi|Ti, δi,yi1, ...,yiL;θm)E(bi|Ti, δi,yi1, ...,yiL;θm)T
3. Since the fixed effect coefficients of each longitudinal model, βl, are involved in both
the longitudinal and survival models, there is no closed form solution. The one-step
Newton-Raphson algorithm can be implemented to update βl:
βˆ
m+1
l = βˆ
m
l −
(
∂S(βˆ
m
l )/∂βl
)−1
S(βˆ
m
l ), l = 1, ..., L,
where the score functions are
S(βl) =
n∑
i=1
1
σ2l
XTil
(
yil −XTilβl − ZTilE(bi|Ti, δi,yi1, ...,yiL;θm)
)
+δiαl
∂F
(
XTl (Ti)βl + Z
T
l (Ti)bil
)
∂βl
− exp(γTwi)
∫ ∫ Ti
0
h0(u)
∂ exp
(∑L
l=1 αlF
(
XTil(u)βl + Z
T
il(u)bi
))
∂βl
p(bi|Ti, δi,yi1, ...,yiL;θm)dudbi,
for l = 1, ..., L. The derivatives ∂S(βˆ
m
l )/∂βl can be calculated by numerical approxi-
mations.
4. Parameters in the survival model can be similarly updated using the Newton-Raphson
algorithm. Score equations used in the Newton-Raphson algorithm are:
S(γ) =
n∑
i=1
wi
{
δi − exp(γTwi)
∫ ∫ Ti
0
h0(u) exp
(
L∑
l=1
αlF
(
XTil(u)βl + Z
T
il(u)bi
))
p(bi|Ti, δi,yi1, ...,yiL;θm)dudbi
}
.
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S(αl) =
n∑
i=1
δi
∫
F
(
XTl (Ti)βl + Z
T
l (Ti)bil
)
dbi
− exp(γTwi)
∫ ∫ Ti
0
h0(u)F
(
XTil(u)βl + Z
T
il(u)bi
)
exp
(
L∑
l=1
αlF
(
XTil(u)βl + Z
T
il(u)bi
))
p(bi|Ti, δi,yi1, ...,yiL;θm)dudbi,
where l = 1, ..., L, and
S(θh0) =
n∑
i=1
δi
1
h0(Ti;θh0)
∂h0(Ti;θh0)
∂θTh0
− exp(γTwi)
∫ ∫ Ti
0
∂h0(Ti;θh0)
∂θTh0
exp
(
L∑
l=1
αlF
(
XTil(u)βl + Z
T
il(u)bi
))
p(bi|Ti, δi,yi1, ...,yiL;θm)dudbi.
For computation of the expected likelihood function, a pseudo-adoptive Gaussian-Hermit
quadrature rule (Rizopoulos, 2012a) can be used to approximate the integrals. The E-step
and M-step iterate until a pre-specified convergence criterion is met.
3.5.2 Inferences and Goodness-of-fit
After convergence of the EM algorithm, standard errors of estimated parameters can be
calculated from the observed inverse Hessian matrix, which can be derived from the score
functions using numeric approximations Press et al. (2007). Using the properties of consis-
tency and asymptotic normality of maximum-likelihood estimates, a 95% confidence interval
(CI) of a parameter θ can be derived as:
θˆ ± 1.96× s.e.(θˆ).
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For hypothesis tests involving multiple parameters,
H0 : θ = θ0 vs. H1 : θ 6= θ0,
the Wald test or Score test can be used. The Wald test statistic is given by
W = (θˆ − θˆ0)T I(θˆ0)(θˆ − θˆ0),
where I(θˆ0) denotes the observed information matrix under the null hypothesis. The Score
test statistic is given by
U = ST (θˆ0){I(θˆ0)}−1S(θˆ0),
where S(θˆ0) and I(θˆ0) are the observed score function and information matrix under the
null hypothesis.
The Likelihood Ratio Test (LRT) is a commonly used statistic to compare nested models,
given by
LRT = −2{l(θˆ0)− l(θˆ)},
where l() is the log joint likelihood function, θˆ0 and θˆ are the corresponding maximum-
likelihood estimates under the null and alternative hypotheses respectively. For non-nested
models, the Akaike’s Information Criterion (AIC) Akaike (1987) and Bayesian Information
Criterion (BIC) Schwarz (1978) are often used for model selection:
AIC = −2l(θˆ) + 2k,
BIC = −2l(θˆ) + k log(n),
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where k denotes the number of parameters in the model and n is the number of subjects in
the data.
3.6 Simulation Study
We performed Monte Carlo (MC) simulations to assess the performance of the proposed
method and compare with the two-stage method. We simulated data from joint models with
two correlated normally distributed longitudinal variables and a time-to-event variable. For
each MC data set, longitudinal data were simulated for 500 subjects each with 10 equally
spaced bivariate longitudinal measures over a 5-year period. We considered similar fixed
and random model structures for the two longitudinal outcomes, where the fixed effects
included time effect, and one binary baseline covariate, and the random effects included
random intercept and random slope. The correlation between the two longitudinal outcomes
is represented by the correlation between the two random intercepts. The longitudinal
models are:
y1(tij) = y
∗
1(tij) + 1(tij) = β01 + β11tij + β21wi + b01i + b11iti + 1(tij),
y2(tij) = y
∗
2(tij) + 2(tij) = β02 + β12tij + β22wi + b02i + b12iti + 2(tij),
where 1(tij) ∼ N(0, σ21), 2(tij) ∼ N(0, σ22) and
(b01i, b11i, b02i, b12i)
T ∼ N


0
0
0
0

,

σ201 0 ρσ01σ02 0
0 σ211 0 0
ρσ01σ02 0 σ
2
02 0
0 0 0 σ212


.
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The time-to-event endpoint was simulated from a Cox model with a Weibull baseline
hazard function, h0(t) = abt
b−1, where a and b are the shape and scale parameters respec-
tively. The Cox model is assumed to depend on the current values of the two longitudinal
outcomes and can be expressed as
h(t) = abtb−1 exp(α1y∗1(t) + α2y
∗
2(t)).
To simulate the event times, we first simulated a survival probability, si, from Uniform(0,1)
for each subject and then solved for T ∗i using two R functions R Development Core Team
(2007), integrate() and uniroot(), from the following equation:
si − exp
{
−
∫ T ∗i
0
abub−1 exp(α1y∗1(u) + α2y
∗
2(u))du
}
= 0.
Censoring times were independently simulated from another uniform distribution. Overall,
the censoring percentage is about 30%. Because of censoring, there were about 6 repeated
bivariate measurements per subject. In the actual model fitting, we used a more flexible
piecewise constant baseline hazard function instead of the parametric Weibull baseline risk
function.
Several simulation scenarios were considered, varying in variances of residual errors,
variance-covariance matrix of the random effects, and the correlation between the two lon-
gitudinal outcomes. Specifically, four scenarios were considered. The true parameter values
used in the simulations were summarized in Table 3.1 and Table 3.2.
Simulation results are presented in Tables 3.3, 3.4, 3.5 and 3.6. We reported relative
biases, empirical standard errors, model-based standard errors, and coverage probabilities
of the 95% CIs based on 500 MC data sets. For the variance-covariance matrix of the
66
Table 3.1: True parameter values for the four scenarios of simulation studies.
Scenario 1 Scenario 2 Scenario 3 Scenario 4
Parameter Value Parameter Value Parameter Value Parameter Value
σ1 0.1 σ1 0.5 σ1 0.1 σ1 0.5
σ2 0.1 σ2 0.5 σ2 0.1 σ2 0.5
σ01 0.1 σ01 0.5 σ01 0.1 σ01 0.5
σ11 0.04 σ11 0.2 σ11 0.04 σ11 0.2
σ02 0.1 σ02 0.5 σ02 0.1 σ02 0.5
σ12 0.04 σ12 0.2 σ12 0.04 σ12 0.2
ρ 0.2 ρ 0.2 ρ 0.5 ρ 0.5
Table 3.2: True parameter values for the two longitudinal models and proportional hazard
function of simulation studies.
Outcome 1 Outcome 2 Time-to-event outcome
Parameter Value Parameter Value Parameter Value
β01 0.2 β02 1.0 a 0.005
β11 0.5 β12 0.2 b 1.1
β21 0.2 β22 0.5 α1 1.0
α2 1.5
random effects, D, we reported the results of its cholesky decomposition, where
chol(D) =

D11 0 D13 0
0 D22 0 0
0 0 D33 0
0 0 0 D44

.
For scenarios 1 and 3 (small variances), both the two-stage approach and EM algorithm
generally performed well: estimated parameters have low relative bias (defined as (θtrue −
θˆ)/θtrue), and coverage probability rates of 95% CIs are around the nominal level. However,
in scenarios 2 and 4 (large variances), the two-stage approach leads to poor results whereas
67
the EM algorithm maintains good performance with small relative bias and good coverage
probability rates of 95% CIs. In particular, the two-stage approach tends to underestimate
the two association parameters, α1 and α2 . In addition, it is observed the correlations
between the two longitudinal outcomes have little impact on the parameter estimation.
We also conducted a simulation study to compare the performance of the EM algorithm
with small and large censoring percentages. We simulated 500 MC samples with 60%
censoring percentage using the same parameter setup as in scenario 4. Results are presented
in Table 3.7, showing that the EM algorithm performs satisfactorily even with 60% censoring
data.
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3.7 Data Application
We applied joint models to the aforementioned primary care patient cohort data using 797
male patients. Our focus was to determine whether and how longitudinal BP measures were
associated with the time to CAD. For convenience we centered patients’ baseline age at 60
years. We fitted four different sets of joint models using the proposed EM algorithm. The
best set of models were determined using the AIC. The 4 sets of joint models are as follows.
Joint models 1 consider the following models
yl(tij) = y
∗
l (tij) + ijl
= β0l + β1ltij + β2lagei + β3lracei + b0li + b1litij + ijl, l = 1, 2 (3.3)
for the observed longitudinal systolic and diastolic BP measures respectively. In the above
longitudinal model, age and race, two well-known factors correlated with systolic and dias-
tolic BP are included as fixed effects. The random effect vector bi = (b01i, b11i, b02i, b12i)
T
is normally distributed with mean zero and an unstructured variance-covariance matrix of
D; ij1 and ij2 are independently distributed as N(0, σ
2
1) and N(0, σ
2
2) respectively. The
hazard function satisfies
h(t) = h0(t) exp {γ1agei + γ2smokei + γ3racei + γ4diabetesi + α1y∗i1(t) + α2y∗i2(t)} ,(3.4)
where the piecewise constant function h0(t) consists of 7 equally spaced intervals with 6
interior knots based on percentiles of the observed event time points. The above hazard
function depends on the current values of systolic and diastolic BP measures and some
common risk factors of CAD, age, smoking history, race and diabetes status.
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Joint models 2 assume the same longitudinal models (3.3) as in the joint models 1, but
use the slopes of systolic and diastolic BP measures in the hazard function instead,
h(t) = h0(t) exp
{
γ1agei + γ2smokei + γ3racei + γ4diabetesi + α1y
∗′
i1(t) + α2y
∗′
i2(t)
}
.(3.5)
Joint models 3 assume the same hazard model (3.4) in the joint model 1, but include a
quadratic fixed time effect for both systolic and diastolic BP measures,
yl(tij) = y
∗
l (tij) + ijl
= β0l + β1ltij + β2lt
2
ij + β3lagei + β4lracei + b0li + b1litij + ijl, l = 1, 2. (3.6)
Joint models 4 assumes (3.5) and (3.6).
In the implementation of the EM algorithm, we used 3 pseudo-adaptive Gaussian-
Hermite quadrature points for numerical integration over the random effects and 7 Gaussian-
Kronrod quadrature points for the integration in the survival function. Estimated param-
eters for the four sets of joint models are presented in Tables 3.8, 3.9, 3.10, and 3.11
respectively. Models were compared according to AIC: smaller AIC indicates better model
fit. Among the 4 joint models considered, Joint models 3 was the best fitting (AIC=65786)
followed by Joint models 4 (AIC=65798), Joint models 2 (AIC=65885) and Joint models 1
(AIC=65898). Here we focus on Joint models 3 for inference and interpretation.
It can be seen that systolic BP measures are significantly associated with the risk of
developing CAD. Each 10 unit increase of systolic BP is associated with 1.23-fold increase
(95% CI:[1.05, 1.5]) in patient’s risk of developing CAD. In addition we observe that di-
astolic BP measures are not significantly associated with the risk of developing CAD once
systolic BP measures were adjusted in the model. The fitted model also identified several
other risk factors for CAD, i.e. participants with older age, being Caucasian and smokers
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have higher risk of CAD. The fitted longitudinal quadratic growth models suggested that
there is a quadratic increasing-then-decreasing trend for systolic BP measures, whereas a
decreasing-then-increasing quadratic trend for diastolic BP measures was seen. In Figure3.2
we plotted subject-specific fitted curves under fitted Joint model 3 for 4 CAD and 4 non-
CAD participants, randomly selected from the study population. It can be seen that the
quadratic longitudinal models fit the data relatively well.
As a comparison, we also fitted two separate single longitudinal measure joint models,
one using systolic BP only and the other diastolic BP only, while adjusting for the same
covariates as in (3.6) above. The two separate joint models showed that both systolic
and diastolic BP were significantly associated with CAD risk. Our joint models 3 takes
the correlation between the two BP measures into consideration and our results indicate
that systolic BP had higher impact on the risk of CAD than diastolic BP in this elderly
population.
We also analyzed the data using alternative methods including the two-stage approach,
Cox model with baseline BP measures, and Cox model with time-dependent BP measures.
In the two Cox models we adjusted for the same baseline risk factors as in (3.4). Figure 3.3
plots the estimated parameter, αˆ1, for systolic BP and their corresponding 95% CIs from
4 different methods: the EM algorithm (Joint models 3), the two-stage method (Joint
models 3), the Cox model with time-dependent covariates and the Cox model with baseline
BP measures. It can be seen that joint models using the EM algorithm has the largest
parameter estimate among all the methods. The under estimation of the two-stage method
was expected given the results from the simulation study. Nevertheless, both joint modeling
approaches (EM algorithm and two-stage approach) point to stronger associations between
systolic BP and CAD than the two Cox models.
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Figure 3.2: Fitted subject-specific longitudinal BP curves for randomly selected 4 CAD and
4 non-CAD subjects based on fitted Joint models 3. The black dots and black solid curves
represent the observed systolic BP overtime and fitted subject-specific curves respectively.
The blue dots and blue solid curves represent the observed diastolic BP overtime and fitted
subject-specific curves respectively.
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Figure 3.3: Comparison of estimated association (αˆ1) between the longitudinal systolic BP
and risk of CAD from four methods. The blue solid dots are estimated αˆ1 from the four
methods. The upper and lower bars are 95% CI of parameter estimates. The red dashed
line denotes the estimate from the EM algorithm.
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Table 3.8: Parameter estimates, standard errors and 95%CI for the joint Models 1. α1 and
α2 are the association estimates between the risk of CAD and current value of systolic and
diastolic BP at event time point, respectively. λi i = 1, ..., 7 denote the baseline hazards of
the 7 piecewise constant intervals.
Parameter Estimate StdErr lower 95%CI upper 95%CI
Longitudinal Systolic BP
Intercept 136.14 0.76 134.65 137.63
time -0.25 0.08 -0.41 -0.10
Age -0.00 0.05 -0.11 0.11
Race 4.54 0.80 2.97 6.12
log(σ1) 2.48 0.01 2.45 2.50
Longitudinal Diastolic BP
Intercept 78.69 0.32 78.06 79.32
time -1.07 0.04 -1.14 -0.99
Age -0.12 0.02 -0.16 -0.08
Race 2.63 0.32 2.01 3.25
log(σ1) 1.95 0.01 1.92 1.97
Time-to-CAD
Age 0.05 0.01 0.03 0.07
Smoking History 0.36 0.15 0.07 0.65
Race -0.47 0.15 -0.77 -0.18
Diabetes -0.03 0.14 -0.31 0.25
α1 0.03 0.01 0.01 0.04
α2 -0.004 0.01 -0.03 0.02
log(λ1) -7.45 0.79 -9.01 -5.89
log(λ2) -7.90 0.80 -9.46 -6.34
log(λ3) -7.59 0.79 -9.14 -6.04
log(λ4) -6.94 0.77 -8.46 -5.42
log(λ5) -6.25 0.76 -7.74 -4.75
log(λ6) -6.40 0.75 -7.88 -4.93
log(λ7) -5.89 0.75 -7.36 -4.42
79
Table 3.9: Parameter estimates, standard errors and 95%CI for the joint Models 2. α1 and
α2 are the association estimates between the risk of CAD and slope of systolic and diastolic
BP at event time point, respectively. λi i = 1, ..., 7 denote the baseline hazards of the 7
piecewise constant intervals.
Parameter Estimate StdErr lower 95%CI upper 95%CI
Longitudinal Systolic BP
Intercept 136.18 0.76 134.70 137.66
time -0.26 0.08 -0.41 -0.10
Age -0.00 0.05 -0.11 0.11
Race 4.49 0.80 2.92 6.06
log(σ1) 2.48 0.01 2.45 2.50
Longitudinal Diastolic BP
Intercept 78.69 0.32 78.06 79.32
time -1.06 0.04 -1.14 -0.99
Age -0.12 0.02 -0.16 -0.07
Race 2.62 0.32 2.00 3.24
log(σ1) 1.95 0.01 1.92 1.97
Time-to-CAD
Age 0.05 0.01 0.03 0.07
Smoking History 0.35 0.15 0.06 0.64
Race -0.38 0.15 -0.67 -0.09
Diabetes 0.00 0.14 -0.27 0.28
α1 0.41 0.19 0.04 0.78
α2 -0.38 0.25 -0.87 0.11
log(λ1) -4.26 0.35 -4.94 -3.58
log(λ2) -4.70 0.36 -5.41 -4.00
log(λ3) -4.38 0.35 -5.07 -3.69
log(λ4) -3.74 0.32 -4.37 -3.10
log(λ5) -3.06 0.31 -3.66 -2.46
log(λ6) -3.22 0.30 -3.81 -2.64
log(λ7) -2.71 0.30 -3.30 -2.12
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Table 3.10: Parameter estimates, standard errors and 95%CI for the joint Models 3. α1 and
α2 are the association estimates between the risk of CAD and current value of systolic and
diastolic BP at event time point, respectively. λi i = 1, ..., 7 denote the baseline hazards of
the 7 piecewise constant intervals.
Parameter Estimate StdErr lower 95%CI upper 95%CI
Longitudinal Systolic BP
Intercept 135.53 0.80 133.95 137.10
time 0.26 0.16 -0.06 0.57
time2 -0.03 0.01 -0.05 -0.01
Age 0.01 0.06 -0.10 0.11
Race 4.40 0.82 2.78 6.01
log(σ1) 2.47 0.01 2.45 2.50
Longitudinal Diastolic BP
Intercept 79.42 0.34 78.75 80.09
time -1.64 0.09 -1.82 -1.46
time2 0.06 0.01 0.05 0.07
Age -0.13 0.02 -0.18 -0.09
Race 2.74 0.32 2.11 3.36
log(σ1) 1.94 0.01 1.92 1.97
Time-to-CAD
Age 0.06 0.01 0.04 0.08
Smoking History 0.35 0.15 0.06 0.65
Race -0.49 0.15 -0.78 -0.19
Diabetes -0.00 0.14 -0.28 0.28
α1 0.021 0.008 0.005 0.038
α2 0.011 0.014 -0.017 0.039
log(λ1) -7.73 0.80 -9.30 -6.17
log(λ2) -8.17 0.80 -9.74 -6.61
log(λ3) -7.85 0.79 -9.41 -6.29
log(λ4) -7.19 0.78 -8.72 -5.66
log(λ5) -6.49 0.77 -8.00 -4.98
log(λ6) -6.61 0.76 -8.10 -5.12
log(λ7) -6.03 0.75 -7.50 -4.55
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Table 3.11: Parameter estimates, standard errors and 95%CI for the joint Models 4. α1 and
α2 are the association estimates between the risk of CAD and slope of systolic and diastolic
BP at event time point, respectively. λi i = 1, ..., 7 denote the baseline hazards of the 7
piecewise constant intervals.
Parameter Estimate StdErr lower 95%CI upper 95%CI
Longitudinal Systolic BP
Intercept 135.54 0.80 133.96 137.11
time 0.24 0.16 -0.07 0.55
time2 -0.03 0.01 -0.05 -0.01
Age 0.00 0.06 -0.10 0.11
Race 4.40 0.82 2.79 6.02
log(σ1) 2.47 0.01 2.45 2.50
Longitudinal Diastolic BP
Intercept 79.41 0.34 78.74 80.08
time -1.64 0.09 -1.82 -1.46
time2 0.06 0.01 0.05 0.07
Age -0.13 0.02 -0.18 -0.09
Race 2.73 0.32 2.11 3.35
log(σ1) 1.94 0.01 1.92 1.97
Time-to-CAD
Age 0.05 0.01 0.04 0.07
Smoking History 0.34 0.15 0.05 0.63
Race -0.38 0.15 -0.67 -0.09
Diabetes 0.05 0.14 -0.23 0.32
α1 0.11 0.17 -0.23 0.45
α2 0.18 0.24 -0.30 0.65
log(λ1) -3.73 0.48 -4.67 -2.79
log(λ2) -4.19 0.44 -5.06 -3.32
log(λ3) -3.89 0.39 -4.65 -3.13
log(λ4) -3.28 0.31 -3.89 -2.67
log(λ5) -2.63 0.25 -3.13 -2.14
log(λ6) -2.83 0.21 -3.24 -2.42
log(λ7) -2.38 0.26 -2.89 -1.86
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3.8 Conclusion
We developed a maximum-likelihood method using the EM algorithm for parameter esti-
mation of joint models for multiple longitudinal processes and a time-to-event outcome.
Simulation studies indicated adequate performance of the EM based estimation approach
which performed better than the two-stage estimation approach. We also applied the pro-
posed method to data from a primary care patient cohort using EMR data for longitudinal
systolic and diastolic BP and investigating their associations with the risk of CAD.
Our current work focused on joint models with normally distributed longitudinal out-
comes. It is worth noting that the proposed methodology can be extended to joint models
with other distributions for the longitudinal outcomes such as binary, Poisson and others.
The proposed EM algorithm can be used for estimation from joint models with mixed types
of longitudinal outcomes. Other potential extensions include compete-risk models or semi-
compete-risk models to take informative censoring into consideration. Another area for
further research is on predictive accuracy based on the proposed joint models.
The methodology for joint models of multiple longitudinal processes and time-to-event
outcome is applicable to many clinical and epidemiologic studies where the association be-
tween longitudinal measures and time-to-event outcome is often of interest. The joint model
framework provides a platform for exploring various features of the longitudinal measures
related to disease risk, extending the traditional approach that relies on baseline measures
only in cohort studies. With the increasing use of EMR in routine clinical practices, joint
models can become a powerful tool for identifying longitudinal risk factors for disease risk
and may offer insights for potential disease mechanisms that are otherwise not available
using traditional approaches.
In clinical practice, for clinicians it may be also important to predict patients’ survival
probabilities based on their available multiple longitudinal biomarker measures. In addition,
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the predictive ability of the longitudinal biomarkers in the joint modeling frameworks has
received more and more attentions in the past few years. Rizopoulos (2011) and Njagi et al.
(2013) have accessed the predictive ability of a single longitudinal biomarker in the joint
modeling context. Adding more longitudinal biomarkers may improve the predictive ability
of the risk model. Thus it is worthwhile to study the predictive ability of the multiple
longitudinal biomarkers and to evaluate the improvement in the predictive performance by
adding new longitudinal biomarkers in the joint modeling framework.
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Chapter 4
Dynamic Predictions in Joint Models for Multiple Longitudinal Processes and
Time-to-event Outcome
4.1 Abstract
In medical studies it is common to collect repeated biomarker measures over time along
with the primary time-to-event outcome since these longitudinal biomarkers may be useful
indicators and represent the disease progression. Joint models for longitudinal and survival
data have been used to assess the association between the longitudinal outcomes and time-
to-event outcome. Recently the predictive ability of the longitudinal outcome in joint models
has also received a lot of attention. Recent literatures focus on the prediction in joint
models with one single longitudinal outcome. However, the predictive ability of multiple
longitudinal outcomes in joint models has not been studied even it is more common to
collect multiple longitudinal biomarkers from participants. The question arises naturally -
how much the prediction can be improved by adding new longitudinal biomarkers into the
joint models? In this work, we extended existing approaches to predict conditional survival
probabilities for joint models with multiple longitudinal biomarkers. We also applied novel
prediction metrics to assess the improvement in prediction by adding new longitudinal
outcome into the joint models. In addition, we compared the predictive performance of
joint models to standard Cox models. Performance of proposed methods was assessed via
simulations. The methodology was also applied to a real data set to predict the risk of
coronary artery disease (CAD) using longitudinal systolic and diastolic blood pressures
(BP).
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4.2 Introduction
In Chapter 3, we developed a maximum-likelihood method using the EM algorithm for
the parameter estimation of joint models for multiple longitudinal biomarkers and time-to-
event outcome, where the main interest is to estimate the association between the multiple
longitudinal variables and the risk of event. The repeated biomarker measures overtime
are often useful indicators of the disease progression. The individualized prediction of joint
models has also received an increasing attention in the past few years. In this chapter we
focus on the following two aspects of predictions in joint models: to predict conditional
survival probabilities in a clinical relevant time window, and to use the AUC (Hanley
and McNeil, 1982) and other novel predictive accuracy criteria to evaluate the improved
predictive ability by adding new longitudinal biomarkers into the joint models as well as
the predictive performance comparison between joint models and standard Cox models.
There have been a few studies on prediction of survival probability in the joint modeling
framework. Taylor et al. (2005) considered individualized predictions of disease progression
using the joint models for a linear mixed-effect model and a logistic regression model. Yu
et al. (2008) extended their previous work to the joint models for a linear mixed-effects
model and a survival-cure model. Proust-Lima and Taylor (2009) focused on the disease
recurrence prediction in the content of joint latent class model. Rizopoulos et al. (2013)
developed a Bayesian model averaging approach for the prediction of the joint models. Tay-
lor et al. (2013) predicted the probability of prostate cancer recurrence for a new patient
using joint models and implemented on a web-based calculator. Rizopoulos (2011) studied
an empirical Bayes approach and a MC simulation approach for the dynamic conditional
survival probability predictions of the joint models for a single longitudinal outcome and a
survival outcome. The empirical Bayes approach obtains the survival probability prediction
by directly using the maximum-likelihood parameter estimates and individual prediction of
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random effects, where the individual prediction of random effects is calculated by maxi-
mizing the posterior likelihood function of random effects. The empirical Bayes approach
is computationally easy yet the derivation of the standard error for the survival probabil-
ity is rather difficult. Therefore, a MC simulation approach was proposed by Rizopoulos
et al. (2013). All these previous studies concentrated on predicting the survival probabil-
ity of the joint models for a single longitudinal biomarker and a time-to-event outcome.
To the best of our knowledge, we are not aware of studies which had looked into the sur-
vival probability predictions of the joint models for multiple longitudinal biomarkers and
time-to-event outcome. We extended the empirical Bayes approach and the MC simulation
approach to predict the conditional survival probability of joint models for multiple longitu-
dinal biomarkers and a time-to-event outcome. The proposed methodology was applied to
the longitudinal systolic and diastolic BP measures and time-to-CAD data from a primary
care patient cohort.
Over the past decades, the assessment of predictive accuracy ability for survival analysis
has received a lot of attention. The ROC (AUC) is the most popularly used discriminative
criterion originally established for binary outcomes. Based on the concept of AUC for
binary outcomes, several types of AUC were proposed for survival analysis. Pencina et al.
(2012) provided a thorough review of existing AUCs for time-to-event outcomes. The most
commonly used AUC for survival analysis was proposed by Harrell et al. (1982) and Harrell
et al. (1996) and it has been further studied by Pencina and Agostino (2004). The AUC
assesses the amount of concordance between predicted and observed outcomes comparing
not only events and nonevents but also events that happened at different points in time.
As an update, Uno et al. (2011) recently proposed a censoring-adjusted AUC based on the
definition of Harrell et al. (1982). Chambless and Diao (2006) proposed a different time-
dependent AUC focusing only on comparisons between event and nonevent. Gonen and
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Heller (2005) considered a different way of assessing concordance applicable to proportional
hazards models. Heagerty et al. (2000) proposed a dynamic ROC curve to summarize
the discriminant of biomarker measured at baseline. Heagerty and Zheng (2005) further
proposed ways to obtain estimate of time-dependent sensitivity, specificity and ROC curves
based on the standard Cox regression model. Zheng and Heagerty (2007) and Antolini et al.
(2005) extended to the survival analysis containing time-dependent covariates.
The AUC is a well-developed criterion for evaluating the discriminative ability for a
single model. It has also been used for risk model comparison or evaluation of predictive
ability by adding a new biomarker in medical studies. However, several studies showed that
the AUC is insensitive in risk model comparison and the difference in AUC measures has
no intuitive interpretation since it is only a function of rank but not predicted probabilities
(Cook, 2007; Harrell, 2001; Janes et al., 2008; Moons and Harrell, 2003). Within the past few
years, novel criteria have been proposed to quantify the improvement in model performance
introduced by adding new biomarkers. Cook (2007) proposed a ”reclassification table”
to show how many subjects are reclassified if a new biomarker is added to the existing
model. Pencina et al. (2008) extended the idea of reclassification table and proposed the Net
Reclassification Improvement (NRI), and integrated discrimination improvement (IDI). IDI
is a measure that integrates net reclassification over all possible cut-offs for the probability
of the outcome. It is equivalent to the difference in discrimination slopes of two models
(Yates, 1982), and to the difference in Pearson R2 measures (Pepe et al., 2008), or the
difference in scaled Brier scores (Gerds et al., 2008). Extensions have been made to account
for time-to-event outcomes by Chambless et al. (2011) and Pencina et al. (2011). Uno et al.
(2011) further updated to a more general type of NRI and IDI. Based on the definition
of NRI and IDI, recently Pepe and Janes (2012) and Zheng et al. (2013) defined two new
criteria, above average risk difference (AARD) and mean risk difference (MRD). They found
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that the AARD is equivalent to the NRI for comparing a risk model to the model without
any predictors. In addition, MRD between events and non-events is equivalent to the area
between TPRt(p) and FPRt(p). Within the joint modelling framework, few studies have
looked at the discriminative ability by using AUC (Njagi et al., 2013; Rizopoulos, 2011).
Further more, no studies have investigated the predictive benefit by adding new longitudinal
biomarkers in the joint modeling framework.
In this work, we explored the performance of AUC, AARD and MRD in evaluating the
added predictive ability of a new longitudinal biomarker in the joint modeling framework via
extensive simulations. In addition, we compared the predictive performance of joint models
to standard Cox models. The comparison of the predictive performance of joint models to
Cox time-dependent model is fair and straightforward since both models can incorporate
the longitudinal data. However, when comparing the Cox baseline model to the joint models
and Cox time-dependent model, one should notice that the Cox baseline model can only
utilize the baseline measures of the longitudinal outcomes. Therefore, the joint models and
Cox time-dependent model may be expected to show better prediction performance than
the Cox baseline model. We also demonstrated the use of these criteria using data from
a primary care patient cohort, as well as comparing the predictive performance of joint
models to the aforementioned commonly used models.
The remainder of this chapter is organized as follows: Section 4.3 describes how the
conditional survival probabilities can be estimated from the fitted joint model. Section 4.4
covers the definitions and estimators of the AUC, AARD and MRD in the joint modeling
framework. Section 4.5 reports the results of simulation studies. In Section 4.6 we illustrated
the proposed methodology to the data from a primary care patient cohort. Finally the
chapter is concluded with a discussion in Section 4.7.
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4.3 Predicting Conditional Survival Probabilities
In the last chapter, we focused on the statistical models and the parameter estimation
method (using the EM algorithm) of the joint models for multiple longitudinal processes
and time-to-event outcome. One important feature of this joint modeling framework is that
the longitudinal biomarker trajectories are associated with the risk of event, implying that
the longitudinal biomarker measures are directly related to the survival probabilities. Based
on the maximum-likelihood estimates of the joint models and the multiple longitudinal
measurements up to time t of a given new subject, one can predict the survival probability
at any time point t. However, it may be more clinically relevant to predict the new subject’s
conditional survival probability at a future time point t+ ∆t given the survival up to time
t. Let Yi(t) = {yi1(s), yi2(s), ..., yLi(s); 0 ≤ s ≤ t} denote the ith subject’s longitudinal
biomarker measures up to time t for L different biomarkers and Dn = {Ti, δi,yi1, ...,yiL; i =
1, 2, ..., n} represents the data set on which the joint models were fitted, the conditional
survival probability at time t+ ∆t given the survival up to time t can be written as
si(t+ ∆t|t) = P (Ti ≥ t+ ∆t|Ti > t,Yi(t),Dn;θ),
where Ti represents the new subject’s observed event or censoring time. The conditional
survival probability, si(t+ ∆t|t), can be further decomposed as
si(t+ ∆t|t) = P (Ti ≥ t+ ∆t|Ti > t,Yi(t),Dn;θ)
=
∫
P (Ti ≥ t+ ∆t|Ti > t,Yi(t),bi;θ)p(bi|Ti > t,Yi(t);θ)dbi
=
∫
Si(t+ ∆t|Y∗(t+ ∆t,bi,θ);θ)
Si(t|Y∗(t,bi,θ);θ) p(bi|Ti > t,Yi(t);θ)dbi,
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where Y∗(t,bi,θ) denotes the true multiple longitudinal biomarker measures. One straight-
forward approach to estimate si(t + ∆t|t) is to plug the empirical Bayes estimate of bi
(bˆi = argmaxb{log p(T ∗i > t,Yi(t),b; θˆ)}) and the maximum-likelihood parameter esti-
mates (θˆ) of the joint models into the above formula, leading to
sˆi(t+ ∆t|t) = Si(t+ ∆t|Y
∗(t+ ∆t, bˆi, θˆ); θˆ)
Si(t|Y∗(t, bˆi, θˆ); θˆ)
+O(n−1i ).
This empirical Bayes approach has the advantage of easy computation, but the derivation
of its standard error is complicate and not straightforward. Rizopoulos (2011) proposed the
MC simulation approach to predict conditional survival probabilities. Basically, instead of
directly calculating the conditional survival probability si(t+∆t|t), the predicted conditional
survival probability is summarized from a series of posterior expectation of si(t+∆t|t) which
is formulated as follows:
P (Ti ≥ t+ ∆t|Ti > t,Yi(t),Dn) =
∫
P (Ti ≥ t+ ∆t|Ti > t,Yi(t);θ)p(θ|Dn)dθ
=
∫ ∫
Si(t+ ∆t|Y∗(t+ ∆t,bi,θ);θ)
Si(t|Y∗(t,bi,θ);θ) p(θ|Dn)
p(bi|Ti > t,Yi(t);θ)dθdbi.
The prediction of si(t+ ∆t|t) using the MC simulation approach can be achieved from the
following steps:
Step 1: Randomly simulate θ(m) from a normal distribution N (θˆ, vˆar(θˆ)). Here we use the
asymptotic Bayesian theory (Cox, 1972) and assume that the sample size n is sufficiently
large such that {θ|Dn} can be well approximated by N (θˆ, vˆar(θˆ)).
Step 2: Randomly simulate b
(m)
i from a multivariate t distribution centered at the empirical
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Bayes estimate bˆi, with scale matrix
vˆar(bˆi) = {−∂
2 log p(Ti > t,Yi(t),b; θˆ)
∂bT∂b
|b=bˆi}
−1
and four degrees of freedom.
Step 3: Calculate
s
(m)
i (t+ ∆t|t) =
Si(t+ ∆t|Y∗(t+ ∆t,b(m)i ,θ(m));θ(m))
Si(t|Y∗(t,b(m)i ,θ(m));θ(m))
Step 4: Repeat Step 1 to Step 3 for all the subjects, where m = 1, ...,M denotes the number
of samples.
Step 5: The mean or median of {s(m)i (t + ∆t|t),m = 1, ...,M} is used as the estimate of
si(t + ∆t|t). The square root of the sample variance over {s(m)i (t + ∆t|t),m = 1, ...,M} is
used as the standard error.
It is noted that the conditional survival probability prediction can be progressively
updated as more longitudinal biomarker measurements become available. Such dynamic
predictions can be useful in clinical practice.
4.4 Predictive Accuracy
The predictive accuracy of a survival model includes calibration, discrimination and re-
classification. Calibration focuses on quantifying how close the predicted outcomes are to
the observed outcomes and the discrimination is to quantify how well a model can distin-
guish subjects with event from those who won’t experience event, while reclassification is
to evaluate the incremental values from using new predictors in the model. In this work
we concentrate on the ability of reclassification of new longitudinal biomarker in the joint
modeling framework. Here we propose to define the TPR and FPR using a subject’s risk
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by a future time t, i.e.,
ri(t) = P (Ti ≤ t|Y∗i (t),Dn;θ) = 1− Si(t|Y∗(t,bi,θ);θ),
where the risk at time t, ri(t), depends on the predicted longitudinal biomarker measures
up to time t and the fitted joint models. TPR and FPR for a given threshold p are defined
as follows:
TPRt(p) = P (r(t) ≥ p|T ≤ t),
FPRt(p) = P (r(t) ≥ p|T > t).
Commonly used estimators of TPR and FPR are defined as in the following,
T̂PRt(p) =
∑n∗
i=1 I(rˆi(t) ≥ p)I(Ti ≤ t)∑n∗
i=1 I(Ti ≤ t)
, (4.1)
F̂PRt(p) =
∑n∗
i=1 I(rˆi(t) ≥ p)I(Ti > t)∑n∗
i=1 I(Ti > t)
, (4.2)
where n∗ denotes the number of subjects experiencing events. Zheng et al. (2013) proposed
another type of estimator by incorporating both censors and events,
T̂PRt(p) =
∑n
i=1 rˆi(t)I(rˆi(t) ≥ p)∑n
i=1 rˆi(t)
, (4.3)
F̂PRt(p) =
∑n
i=1(1− rˆi(t))I(rˆi(t) ≥ p)∑n
i=1(1− rˆi(t))
. (4.4)
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Based on the definition of the AUC, the AUC at time t can be written as
AUCt =
∫
TPRtFPR
−1
t (u)du.
Using the estimates of FPR and TPR, the estimation of AUC can be readily derived,
ÂUCt =
∫
T̂PRtF̂PR
−1
t (u)du.
The newly proposed AARD and MRD (Pepe and Janes, 2012; Zheng et al., 2013) can also
be defined by the risk function, r(t):
AARD = P (r(t) > ρt|T ≤ t)− P (r(t) > ρt|T > t),
MRD = E(r(t)|T ≤ t)− E(r(t)|T > t),
where ρt = P (T ≤ t). Similarly, the estimation of AARD and MRD can be written as
follows:
̂AARDt = T̂PRt(ρˆ)− F̂PRt(ρˆ),
M̂RDt =
∫
p
T̂PRt(p)dp−
∫
p
F̂PRt(p)dp,
where
ρˆ =
1∑n
i=1 rˆi(t)
.
4.5 Simulation Study
We used simulations to assess performance of the empirical Bayes approach and the MC
simulation approach in predicting conditional survival probabilities of joint models for mul-
tiple longitudinal biomarkers and a time-to-event outcome. Performance of aforementioned
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three criteria for evaluating the improvement in predictive ability by adding new biomarkers
was also investigated via extensive simulations.
The joint models described in the simulation section of the previous chapter were used to
generate data. Three simulation scenarios were considered by varying variances of residual
errors and variance-covariance matrix of random effects. The three scenarios are presented
in Table 4.1. All other true parameter values were summarized in Table 4.2. Two hundred
training data sets were generated for each scenario. Each training data set consists of 500
subjects with each subject having up to 11 equally spaced bivariate longitudinal evaluations
over a 5 year period. Additional 200 testing data sets were simulated using the same
covariate values and random effects as in training data sets for each scenario .
Table 4.1: Three scenarios differing in variances of residual errors and variances of random
effects used in simulations.
Parameter Scenario 1 Scenario 2 Scenario 3
σ1 0.2 0.2 0.5
σ2 0.2 0.2 0.5
σ01 0.2 0.5 0.5
σ11 0.05 0.2 0.2
σ02 0.2 0.5 0.5
σ12 0.05 0.2 0.2
Table 4.2: Other true parameter values for the two longitudinal models and the Cox PH
model used in simulations.
Outcome 1 Outcome 2 Time-to-event outcome
Parameter Value Parameter Value Parameter Value
β01 0.2 β02 1.0 a 0.005
β11 0.5 β12 0.2 b 1.1
β21 0.2 β22 0.5 α1 1.0
ρ 0.5 α2 1.0
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4.5.1 Predicting Conditional Survival Probabilities
We fitted joint models to each training data set and estimated parameters using the EM
algorithm. For each testing data set, data from the first 2 years was used to predict in-
dividual random effects. Twenty subjects were randomly selected from each testing data
set. Selected subjects’ conditional survival probabilities at different times t (t > 2) and ∆t
were predicted via the empirical Bayes approach and the MC simulation approach, using
the estimated parameters from training data set and predicted individual random effects
from the first 2 year testing data. In the MC simulation approach, the median based on
200 MC replicates was used as the predicted conditional survival probability. Predicted
conditional survival probabilities obtained from the two approaches were compared to the
true predictions based on the true random effects and true parameter values. We reported
the average biases between the true and predicted conditional survival probabilities for the
selected subjects over the 200 testing data sets.
Simulation results for the three scenarios are presented in Tables 4.3, 4.4 and 4.5.
From simulation results, it is evident that for scenario 1 (small variances of residual errors
and small variances of random effects), the performance of the empirical Bayes approach is
fairly comparable to that of the MC simulation approach: the biases in conditional survival
probability predictions are ignorable. However, under the large variance scenarios 2 and
3, the MC simulation approach generally performs better in predicting conditional survival
probabilities than the empirical Bayes approach - smaller biases are observed for the MC
simulation approach. In addition, the results clearly show that for fixed ∆t, biases increase
as time t increases. This may be explained by the fact that more subjects drop out as
time t increases leading to less accurate random effect predictions. On the other hand, the
results also indicate that for fixed time t, biases generally increase as the prediction window
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∆t increases. In other words, conditioning on the same number of longitudinal biomarker
measures, the performance of prediction gets worse when window for prediction is longer.
4.5.2 Predictive Accuracy
Additional simulations were conducted to examine the performance of AUC, AARD and
MRD in evaluating the predictive ability of joint models. The predictive performance of
joint models were also compared to other commonly used models. In each training data
set we fitted the following four models: the Cox PH model with longitudinal biomarker
measures at baseline as time-independent covariates (Cox baseline), Cox PH model with
longitudinal biomarker measures as time-dependent (Cox time-dependent), joint models
of the first longitudinal biomarker and time-to-event outcome (JM1), and joint models of
bivariate longitudinal biomarkers and time-to-event outcome (JM2). For JM1 and JM2
models, individual survival probabilities at time t (t > 2) for subjects from testing data
set were obtained using the similar procedures as described for predicting conditional sur-
vival probabilities in the previous section. For the Cox baseline model, individual survival
probabilities were calculated using the estimated parameters from the training data set and
longitudinal measures at baseline from the testing data. The same technique was applied
for the Cox time-dependent model, except for using the longitudinal measures up to time
t from the testing data. Based on predicted survival probabilities and estimators for TPR
and FPR (formulas (4.1) and (4.2)), TPR and FPR can be readily calculated for differ-
ent models. Accordingly, AUC, AARD and MRD were derived from these TPR and FPR
values.
The sample means and empirical standard errors of AUC, AARD, and MRD for the four
models were summarized over the 200 testing data sets for each scenario. Simulation results
with respect to different scenarios are presented in Tables 4.6, 4.7 and 4.8. It is shown that
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among the four models, JM2 has the best predictive performance - little differences were
observed between the true predictive accuracy criteria (calculated based on true random
effects and true parameters) and the calculated predictive accuracy criteria based on JM2.
From results of JM2 we observe that the predictive performance improves as the time t
increases. It is also evident that the variances of residual of errors and random effects have
some impact on the predictive performance: larger variances of residual of errors lead to
larger biases (Tables 4.7 and 4.8); larger variances of random effects also result in larger
biases (Tables 4.6 and 4.7).
Simulation results of JM1 and JM2 show that for large prediction window t, AUC seems
be able to reflect the improvement of predictive ability by adding the second longitudinal
biomarker. However, when the prediction window t is small, little improvement was ob-
served in AUC. The cause of such phenomenon may be that for large prediction window t
the effect on the survival from the second longitudinal outcome may be large enough for
AUC to capture the predictive improvement; whereas for small prediction window t, the
effect from the second longitudinal outcome is not large enough for AUC to reflect the
predictive improvement. This observed phenomenon of insensitivity of AUC is similar to
discussions in Janes et al. (2008). Compared to AUC, AARD and MRD seem to be more
sensitive in measuring the improvement of predictive ability from the second longitudinal
biomarker.
Simulation results also reveal persistent biases between true predictive criteria (calcu-
lated based on true random effects and true parameter values) and calculated criteria from
JM2. We notice that AUC, AARD, and MRD rely on predicted survival probabilities. Thus
the precision of parameter estimates and the random effect predictions are directly related
to precision of predictive accuracy criteria. Extra simulations were conducted to determine
how the accuracy of random effect predictions and parameter estimates influence the per-
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formance of the predictive criteria. We defined two types of pseudo survival probability
estimators: using true random effects and estimated parameter values (Pseudo 1) and us-
ing predicted random effects and true parameter values (Pseudo 2). Simulation results are
presented in Tables 4.9, 4.10 and 4.11. It is observed that both the accuracy of parameter
estimates and random effect predictions have impact on the precision of predictive criteria.
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Table 4.6: Comparison of AUC, AARD, and MRD from JM2 to the other 3 models under
simulation scenario 1.
Cox(Baseline) Cox(time-dependent) JM1 JM2
t True Mean ESD Mean ESD Mean ESD Mean ESD
AUC
3 0.659 0.634 0.028 0.501 0.031 0.624 0.029 0.649 0.028
3.5 0.673 0.643 0.026 0.497 0.029 0.634 0.028 0.662 0.027
4 0.692 0.657 0.026 0.497 0.028 0.644 0.027 0.679 0.027
4.5 0.715 0.672 0.026 0.496 0.029 0.657 0.025 0.699 0.025
5 0.745 0.691 0.027 0.499 0.032 0.676 0.026 0.725 0.025
AARD
3 0.230 0.198 0.048 0.013 0.054 0.180 0.051 0.219 0.048
3.5 0.252 0.210 0.045 -0.002 0.050 0.194 0.051 0.237 0.048
4 0.281 0.232 0.045 -0.018 0.049 0.211 0.047 0.262 0.048
4.5 0.316 0.255 0.043 -0.036 0.052 0.226 0.047 0.293 0.048
5 0.363 0.283 0.048 -0.043 0.055 0.254 0.047 0.331 0.044
MRD
3 0.065 0.044 0.015 0.003 0.013 0.028 0.009 0.055 0.014
3.5 0.088 0.058 0.018 0.000 0.016 0.040 0.011 0.075 0.017
4 0.113 0.073 0.020 -0.002 0.018 0.052 0.013 0.096 0.020
4.5 0.134 0.084 0.022 -0.004 0.019 0.062 0.014 0.114 0.021
5 0.147 0.088 0.022 -0.002 0.020 0.069 0.014 0.125 0.021
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Table 4.7: Comparison of AUC, AARD, and MRD from JM2 to the other 3 models under
simulation scenario 2.
Cox(Baseline) Cox(time-dependent) JM1 JM2
t True Mean ESD Mean ESD Mean ESD Mean ESD
AUC
3 0.791 0.738 0.026 0.683 0.027 0.720 0.025 0.774 0.023
3.5 0.811 0.737 0.023 0.686 0.024 0.728 0.023 0.790 0.021
4 0.830 0.736 0.022 0.688 0.023 0.733 0.022 0.805 0.019
4.5 0.851 0.734 0.022 0.692 0.022 0.738 0.023 0.819 0.018
5 0.871 0.735 0.022 0.697 0.023 0.745 0.023 0.834 0.017
AARD
3 0.434 0.348 0.048 0.263 0.048 0.323 0.047 0.407 0.046
3.5 0.465 0.345 0.043 0.267 0.042 0.335 0.043 0.433 0.041
4 0.502 0.343 0.042 0.264 0.042 0.342 0.043 0.454 0.039
4.5 0.540 0.341 0.042 0.267 0.042 0.347 0.042 0.478 0.039
5 0.582 0.343 0.044 0.270 0.044 0.355 0.042 0.503 0.038
MRD
3 0.258 0.130 0.026 0.161 0.028 0.088 0.018 0.203 0.025
3.5 0.303 0.146 0.027 0.175 0.027 0.108 0.021 0.241 0.025
4 0.337 0.153 0.026 0.173 0.026 0.125 0.023 0.270 0.025
4.5 0.362 0.154 0.026 0.164 0.026 0.136 0.023 0.292 0.024
5 0.379 0.149 0.025 0.155 0.026 0.145 0.024 0.306 0.024
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Table 4.8: Comparison of AUC, AARD, and MRD from JM2 to the other 3 models under
simulation scenario 3.
Cox(Baseline) Cox(time-dependent) JM1 JM2
t True Mean ESD Mean ESD Mean ESD Mean ESD
AUC
3 0.791 0.696 0.027 0.659 0.028 0.696 0.025 0.749 0.024
3.5 0.811 0.696 0.025 0.663 0.025 0.704 0.023 0.763 0.021
4 0.830 0.694 0.022 0.665 0.024 0.709 0.022 0.775 0.019
4.5 0.851 0.693 0.023 0.669 0.023 0.713 0.023 0.786 0.019
5 0.871 0.694 0.024 0.675 0.024 0.717 0.022 0.798 0.019
AARD
3 0.434 0.288 0.048 0.231 0.048 0.288 0.045 0.368 0.050
3.5 0.465 0.285 0.044 0.233 0.044 0.299 0.043 0.388 0.041
4 0.502 0.281 0.042 0.229 0.043 0.303 0.045 0.405 0.038
4.5 0.540 0.278 0.042 0.231 0.044 0.308 0.046 0.420 0.039
5 0.582 0.279 0.043 0.233 0.045 0.311 0.042 0.436 0.038
MRD
3 0.258 0.084 0.022 0.112 0.024 0.071 0.016 0.154 0.021
3.5 0.303 0.097 0.023 0.127 0.024 0.089 0.019 0.186 0.022
4 0.337 0.103 0.023 0.127 0.023 0.103 0.020 0.211 0.022
4.5 0.362 0.104 0.023 0.119 0.022 0.114 0.021 0.230 0.022
5 0.379 0.102 0.022 0.108 0.022 0.121 0.021 0.244 0.022
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Table 4.9: Simulation results for comparing AUC, AARD, and MRD for the three different
survival probability estimators under scenario 1. Pseudo 1 denotes the estimator using
true random effects and estimated parameter values; Pseudo 2 denotes the estimator using
estimated random effects and true parameter values; JM2 denotes the estimator using
estimated random effects and estimated parameters.
Pseudo 1 Pseudo 2 JM2
t True Mean ESD Mean ESD Mean ESD
AUC
3 0.659 0.659 0.027 0.650 0.028 0.649 0.028
3.5 0.673 0.673 0.026 0.664 0.027 0.662 0.027
4 0.692 0.692 0.026 0.682 0.027 0.679 0.027
4.5 0.715 0.715 0.025 0.701 0.025 0.699 0.025
5 0.745 0.745 0.025 0.728 0.025 0.725 0.025
AARD
3 0.230 0.231 0.046 0.218 0.048 0.219 0.048
3.5 0.252 0.252 0.045 0.238 0.049 0.237 0.048
4 0.281 0.282 0.045 0.265 0.048 0.262 0.048
4.5 0.316 0.315 0.046 0.297 0.045 0.293 0.048
5 0.363 0.364 0.043 0.335 0.045 0.331 0.044
MRD
3 0.065 0.067 0.016 0.052 0.012 0.055 0.014
3.5 0.088 0.092 0.020 0.072 0.013 0.075 0.017
4 0.113 0.117 0.024 0.093 0.013 0.096 0.020
4.5 0.134 0.137 0.025 0.110 0.015 0.114 0.021
5 0.147 0.151 0.026 0.123 0.022 0.125 0.021
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Table 4.10: Simulation results for comparing AUC, AARD, and MRD for the three different
survival probability estimators under scenario 2. Pseudo 1 denotes the estimator using
true random effects and estimated parameter values; Pseudo 2 denotes the estimator using
estimated random effects and true parameter values; JM2 denotes the estimator using
estimated random effects and estimated parameter values.
Pseudo 1 Pseudo 2 JM2
t True Mean ESD Mean ESD Mean ESD
AUC
3 0.791 0.791 0.023 0.780 0.023 0.774 0.023
3.5 0.811 0.811 0.021 0.800 0.021 0.790 0.021
4 0.830 0.830 0.018 0.817 0.019 0.805 0.019
4.5 0.851 0.851 0.016 0.835 0.017 0.819 0.018
5 0.871 0.871 0.016 0.853 0.017 0.834 0.017
AARD
3 0.434 0.433 0.048 0.416 0.048 0.407 0.046
3.5 0.465 0.466 0.045 0.445 0.042 0.433 0.041
4 0.502 0.501 0.039 0.474 0.040 0.454 0.039
4.5 0.540 0.540 0.037 0.505 0.039 0.478 0.039
5 0.582 0.583 0.039 0.538 0.038 0.503 0.038
MRD
3 0.258 0.259 0.031 0.222 0.024 0.203 0.025
3.5 0.303 0.303 0.031 0.267 0.022 0.241 0.025
4 0.337 0.335 0.029 0.302 0.022 0.270 0.025
4.5 0.362 0.356 0.028 0.328 0.025 0.292 0.024
5 0.379 0.368 0.028 0.344 0.033 0.306 0.024
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Table 4.11: Simulation results for comparing AUC, AARD, and MRD for the three different
survival probability estimators under scenario 3. Pseudo 1 denotes the estimator using
true random effects and estimated parameter values; Pseudo 2 denotes the estimator using
estimated random effects and true parameter values; JM2 denotes the estimator using
estimated random effects and estimated parameter values.
Pseudo 1 Pseudo 2 JM2
t True Mean ESD Mean ESD Mean ESD
AUC
3 0.791 0.791 0.023 0.757 0.024 0.749 0.024
3.5 0.811 0.810 0.021 0.777 0.022 0.763 0.021
4 0.830 0.830 0.018 0.793 0.020 0.775 0.019
4.5 0.851 0.851 0.016 0.809 0.018 0.786 0.019
5 0.871 0.871 0.016 0.824 0.018 0.798 0.019
AARD
3 0.434 0.432 0.047 0.380 0.049 0.368 0.050
3.5 0.465 0.465 0.044 0.408 0.044 0.388 0.041
4 0.502 0.501 0.038 0.434 0.039 0.405 0.038
4.5 0.540 0.539 0.037 0.461 0.038 0.420 0.039
5 0.582 0.582 0.039 0.486 0.040 0.436 0.038
MRD
3 0.258 0.260 0.032 0.180 0.025 0.154 0.021
3.5 0.303 0.304 0.032 0.225 0.024 0.186 0.022
4 0.337 0.335 0.030 0.259 0.022 0.211 0.022
4.5 0.362 0.357 0.029 0.285 0.024 0.230 0.022
5 0.379 0.369 0.029 0.299 0.032 0.244 0.022
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4.6 Data Application to A Primary Care Patient Cohort
We first applied joint models to the primary care patient cohort data discussed in Chapter
3. Out of the 797 subjects, we randomly selected 597 subjects to create the testing data set
and the remaining 200 subjects comprised the testing data set. For convenience we centered
patients’ baseline age at 60 years. We fitted four different sets of joint models introduced
in Chapter 3 Section 3.7 to the training data set using the proposed EM algorithm. In
the implementation of the EM algorithm, we used 3 pseudo-adaptive Gaussian-Hermite
quadrature points for numerical integration over the random effects and 7 Gaussian-Kronrod
quadrature points for the integration in the survival function. The best set of models were
determined using the AIC: smaller AIC indicates better model fit. Among the 4 joint
models considered, Joint models 3 was the best fitting (AIC=49464) followed by Joint
models 4 (AIC=49475), Joint models 1 (AIC=49537) and Joint models 2 (AIC=49548).
Here we presented parameter estimates from joint models 3 in Table 4.12. The results
imply a similar conclusion as in the data application section of Chapter 3: a high systolic
BP measure is significantly associated with a high risk of CAD, while a non-significant
association with risk of CAD is observed for the diastolic BP measure.
We then used data from the first 5 years in the testing data set to estimate patients’
subject-specific random effects. Based on parameter estimates from the training data set
and the random effect estimates from the first 5 year testing data, predicted conditional
survival probabilities given t (t > 5) were further computed using the MC simulation ap-
proach. In the following we assessed the performance of predictive ability of the joint models
using the testing data set, as well as compared the prediction performance of joint models
with systolic and diastolic BP measures to joint models with one single type of BP measure
(systolic or diastolic) and other standard Cox models.
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4.6.1 Predicting Conditional Survival Probabilities
In this section, we focused on predicting conditional survival probabilities in joint models.
As an example, we chose two subjects from the testing data set to illustrate how the lon-
gitudinal BP measures over time influence the conditional survival probability predictions.
We selected subject 143 and 318 with the same baseline risk covariates. Subject 143 was a
66 years old black male with a history of smoking and diabetes, and was lost to follow up
6.97 years after baseline. Subject 318 had the same demographics as subject 143, except
that a CAD event was observed at year 7.5. The two selected subjects with the same char-
acteristics allowed us to study the pure affect of longitudinal BP measures over time on the
risk of developing CAD. The longitudinal BP measures over time for the two subjects were
plotted in Figure 4.1. It is observed that, in general, longitudinal BP measures of subject
143 increased and then decreased over time, while subject 318 had an increasing and then
decreasing trend in BP measures over time. The two subjects’ predicted conditional survival
probabilities were summarized in Table 4.13 and Figures 4.2 and 4.3. From the two plots,
we clearly observed how the longitudinal BP measures impacted on the risk of developing
CAD. Overall, subject 318 had larger risk in developing CAD than subject 143.
4.6.2 Predictive Accuracy
We assessed the performance of predictive ability of the joint models with longitudinal sys-
tolic and diastolic BP measures (JM2) using the testing data set. Three predictive criteria,
AUC, AARD, and MRD, were considered. When estimating the TPR and FPR, we adopted
estimators proposed by Zheng et al. (2013).Predictive results of JM2 were also compared
to the other commonly used models, including the Cox model with baseline systolic and
diastolic BP measures as fixed covariates, the Cox model with observed longitudinal systolic
and diastolic BP measures as time-dependent covariates, JM1 model with only longitudinal
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Figure 4.1: Observed longitudinal systolic and diastolic BP measures over time for subject
143 and 318. The blue solid line and triangles denotes the observed systolic BP measures
over time. The green solid line and dots depict the observed the diastolic BP measures over
time.
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Figure 4.2: Predicted conditional survival probabilities for subject 143. The solid line
denotes the median of predicted conditional survival probabilities over the 200 MC samples.
The two dashed lines represent the 95% point-wise confidence intervals.
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Figure 4.3: Conditional survival probability predictions for subject 318. The solid line
denotes the median of predicted conditional survival probabilities over the 200 MC samples.
The two dashed lines represent the 95% point-wise confidence intervals.
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Figure 4.4: Time-dependent ROC curves for different models at different time points.
systolic BP, and JM1 with only longitudinal diastolic BP. Prediction performance com-
paring different models and criteria at various time points were presented in Table 4.14.
Time-dependent ROC curves at different time points and various models were illustrated
in Figure 4.4. From these results, it is clear to observe that JM2 model has the best pre-
dictive performance: AUC, AARD and MRD of model JM2 are higher than those of all
the other models. Particularly, model JM2 has better prediction performance than the two
JM1 models indicating that the joint model incorporating both longitudinal systolic and
diastolic BP measures can enhance the predictive ability.
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Table 4.12: Parameter estimates, standard errors and 95%CI using the training data set. α1
and α2 are the association estimates between the risk of CAD and current value of systolic
and diastolic BP at event time point, respectively. λi i = 1, ..., 7 denote the baseline hazards
of the 7 piecewise constant intervals.
Parameter Estimate StdErr lower 95%CI upper 95%CI
Longitudinal Systolic BP
Intercept 135.20 0.96 133.31 137.08
time 0.33 0.18 -0.03 0.69
time2 -0.04 0.01 -0.07 -0.02
Age -0.04 0.06 -0.17 0.08
Race 5.33 0.98 3.41 7.25
log(σ1) 2.49 0.01 2.46 2.52
Longitudinal Diastolic BP
Intercept 79.19 0.40 78.41 79.97
time -1.64 0.11 -1.85 -1.43
time2 0.05 0.01 0.04 0.07
Age -0.13 0.03 -0.18 -0.08
Race 3.18 0.37 2.45 3.90
log(σ1) 1.94 0.01 1.91 1.97
Time-to-CAD
Age 0.06 0.01 0.04 0.08
Smoking History 0.36 0.18 0.01 0.71
Race -0.53 0.19 -0.90 -0.17
Diabetes 0.06 0.17 -0.27 0.40
α1 0.021 0.010 0.001 0.041
α2 0.018 0.017 -0.015 0.050
log(λ1) -8.41 1.00 -10.38 -6.45
log(λ2) -8.79 1.00 -10.75 -6.83
log(λ3) -8.43 1.00 -10.38 -6.47
log(λ4) -7.70 0.98 -9.62 -5.79
log(λ5) -6.96 0.96 -8.85 -5.07
log(λ6) -7.09 0.95 -8.96 -5.22
log(λ7) -6.51 0.92 -8.32 -4.70
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Table 4.13: Conditional survival probability predictions for subject 143 and 318. For the
MC simulation approach, the median of predictions over 200 MC samples is used as the
predicted conditional survival probability. The 2.5% and 97.5% bounds over the 200 MC
samples are also presented.
t (year) ∆t (year) MC simulation approach
Median 2.5%CI 97.5%CI
Subject 143
0 2 0.947 0.912 0.970
4 0.893 0.831 0.932
6 0.781 0.678 0.862
2 2 0.939 0.896 0.963
4 0.820 0.713 0.889
6 0.589 0.422 0.718
4 2 0.879 0.779 0.921
4 0.645 0.461 0.752
6 0.475 0.217 0.609
6 2 0.733 0.565 0.836
4 0.518 0.310 0.669
6 0.357 0.143 0.538
Subject 318
0 2 0.905 0.839 0.953
4 0.814 0.701 0.898
6 0.653 0.487 0.793
2 2 0.906 0.826 0.950
4 0.719 0.527 0.839
6 0.434 0.171 0.631
4 2 0.807 0.639 0.897
4 0.494 0.243 0.699
6 0.293 0.075 0.510
6 2 0.623 0.324 0.772
4 0.365 0.110 0.601
6 0.210 0.027 0.469
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Table 4.14: Data application results for comparing predictive accuracy criteria of different
models.
Cox Cox
t(year) Baseline Time-dependent JM1 (sys BP) JM1 (dias BP) JM2
AUC
8 0.637 0.662 0.646 0.656 0.673
10 0.647 0.664 0.654 0.659 0.678
12 0.652 0.678 0.653 0.674 0.683
15 0.670 0.694 0.670 0.679 0.703
AARD
8 0.197 0.234 0.213 0.221 0.249
10 0.210 0.234 0.221 0.222 0.256
12 0.218 0.253 0.217 0.244 0.264
15 0.245 0.280 0.245 0.252 0.296
MRD
8 0.052 0.072 0.057 0.066 0.083
10 0.067 0.087 0.073 0.077 0.099
12 0.073 0.102 0.074 0.097 0.108
15 0.085 0.114 0.088 0.099 0.127
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4.7 Conclusion
In this chapter we extended the empirical Bayes and the MC simulation approaches (Ri-
zopoulos, 2011) for conditional survival probability prediction in joint models of multiple
longitudinal biomarkers and time-to-event outcome. The simulation studies showed that
the MC simulation approach induced less bias than the empirical Bayes approach under the
large variance scenario. The predicted conditional survival probabilities can be dynamically
updated as more longitudinal biomarker measures are collected, and it can help clinicians
provide better medical cares for patients.
We also evaluated the predictive accuracy of joint models using AUC, AARD and MRD.
Extensive simulations were conducted to assess the performance of proposed methodology.
Simulation results reflected that AARD and MRD are more sensitive than AUC in quan-
tifying the improved predictive ability by adding new longitudinal biomarker in the joint
models. In addition, simulation results implied that joint models have better predictive
accuracy than the commonly used Cox models. In simulations, it is also observed that the
prediction accuracy of random effect has some sort of impact on the predictive accuracy of
joint models. In the future, we plan to study for new approaches to improve accuracy of
random effect prediction in the joint modeling framework.
In clinical trials and observational studies, it’s common to see longitudinal biomark-
ers are also collected besides of the primary time-to-event end point. These longitudinal
biomarkers could be very useful indicators for the disease progression since the underling
trajectories of the longitudinal biomarkers can be very informative. For example, the CD4
cell count measures are often measured in the study of human immunodeficiency virus
(HIV)- the lower CD4 count indicates the higher risk of HIV; in studies of prostate cancer,
the prostate specific antigen (PSA) level is also frequently measured since high PSA is a
strong risk factor of prostate cancer; in cardiovascular disease studies, the data of common
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risk factors, systolic and diastolic blood pressures, lipids and cholesterol levels, are also rou-
tinely collected. A natural question will be whether including the longitudinal biomarker
trajectory in the model can improve the predictive ability of the model as well as how much
improvement can the new longitudinal biomarker provide. The existing methodology of
joint models prediction can only be used to assess the predictive performance of one single
longitudinal biomarker. In reality, multiple longitudinal biomarkers could be associated
with the disease risk. Often times, the biomarker assessment could be highly costly. So
it would be very useful and practical to decide how much prediction improvement can be
gained by adding another new longitudinal biomarker in to the existing model. Our pro-
posed methodology of prediction for joint model with multiple longitudinal outcomes are
well established to answer such questions. In our data application, we demonstrated that
the joint models with both systolic and diastolic BP have better prediction performance
than joint models with only one type of BP measures. The methodology can be applied to
many other clinical or epidemiology studies.
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Chapter 5
Conclusion
In this thesis we have studied several topics related to joint models for longitudinal and
survival data analysis. The proposed methodologies are applicable to many medical research
areas.
In Chapter 2, we developed joint modeling frameworks of bivariate longitudinal out-
comes under three different bivariate random change point models: the bivariate random
broken-stick model, the bivariate random Bacon-Watts model, and the bivariate random
smooth polynomial model. The Bayesian method was used for model fitting using the BRugs
package in R. The proposed bivariate random change point models not only estimate the
change points of bivariate longitudinal outcomes, but also investigate the correlation be-
tween the change points. This methodology is useful for disease prognosis using biomarkers
in medical science, and it also possesses flexibility in model fitting. Although we have fo-
cused on investigating the correlation between the change points, one can readily extend
to more complex models by specifying and estimating other correlation parameters such as
correlation between the two slopes before the change point as well as the two slopes after
the change point in the bivariate model. The extension to multivariate change point models
for multiple longitudinal outcomes is also applicable.
Joint models for multiple longitudinal biomarkers and time-to-event outcome were inves-
tigated in Chapter 3. We developed a maximum-likelihood method using the EM algorithm
for parameter estimation of joint models. We conducted a series of simulations to assess
the performance of EM algorithm in parameter estimation of joint models. The simula-
tions compared the existing two-stage method to the EM algorithm, and confirmed that
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the EM algorithm can provide more accurate and efficient parameter estimates than the
two-stage method. The methodology of joint models for multiple longitudinal processes and
time-to-event outcome are applicable to many clinical trials and observational studies where
the association between multiple longitudinal biomarkers and time-to-event outcome is of
interest. In this work, we focused on joint models with normally distributed longitudinal
outcomes, however, it is straightforward to extend to joint models with various distributed
longitudinal outcomes, including binary, poisson outcome and so on. The proposed EM
algorithm can be used to estimate parameters of joint models with these mixed types of
longitudinal outcomes. On the other hand, we can extend the standard Cox PH models
to compete-risk model or semi-compete-risk model to take into account of non-uniformly
distributed time-to-event outcome.
Last, in Chapter 4 we continued the joint modeling framework in the previous chapter
and focused on the predictive accuracy of joint models. We assessed the MC simulation
approach (Rizopoulos, 2011) for the conditional survival probability prediction in joint
models for multiple longitudinal biomarkers and a time-to-event outcome. The predicted
conditional survival probability can be dynamically updated as more longitudinal biomarker
measures are collected, and it can help clinicians provide better medical cares for patients.
We also evaluated the predictive accuracy of the joint models using AUC, AARD and MRD.
We conducted extensive simulations to assess the performance of proposed methodology.
Simulation results reflect that AARD and MRD are more sensitive than AUC in quantifying
the improved predictive ability introduced by adding new biomarkers in the joint models.
The methodology of the predictive accuracy of the joint models are applicable to many
clinical trials and observational studies.
Joint models of multiple longitudinal outcomes and time-to-event outcome can find
many applications in observational studies or clinical trial settings. Currently many cohort
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studies still rely on baseline measures when determining the associations between putative
risk factors and time to event. Such approaches make the implicit assumption that the
exposure measures stay constant over the observation period. However, in many medical
research areas, such an assumption is unlikely to hold. In aging research, for example, many
biomarkers were found to change with time either as part of the aging process, disease
progression or in response to treatment.
The use of time-dependent Cox models, although no longer requiring the assumption
of constant exposure, has its own limitations, as we described in details in Chapter 3.
The first is that longitudinal exposure levels were assumed to be measured without error;
the second is that trends in the longitudinal processes cannot be used to determine their
association with time to event. The joint modeling framework we used in this research is
capable of including various aspects of the longitudinal outcomes such as current values,
rate of changes or cumulative exposures as part of the model framework so that we can
identify the attributes in the longitudinal outcomes that are most significantly related to
the survival outcome.
The joint modeling framework offers a powerful tool for data collected in routine clinical
practice where biomarkers such as blood pressure, lipids, glucose level and other markers are
collected as part of physical examination conducted at regular intervals. The use of joint
modeling approach can offer prospective prediction of patients’ risk for various diseases
based on the collective longitudinal measures of these marker values and give clinicians a
better tool to synthesize these repeatedly measured marker values. In health care system
with comprehensive electronic medical record data, the modeling and prediction approach
can be incorporated into the system to offer real-time modeling and prediction, providing
on-going decision support to clinicians and leading ultimately to better patients’ care and
health outcomes.
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